<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1113896</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Leaf hydroalcoholic extract and oleoresin from <italic>Copaifera multijuga</italic> control <italic>Toxoplasma gondii</italic> infection in human trophoblast cells and placental explants from third-trimester pregnancy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mart&#xed;nez</surname>
<given-names>Aryani Felixa Fajardo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2120159"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Teixeira</surname>
<given-names>Samuel Cota</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/476866"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Souza</surname>
<given-names>Guilherme</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/645329"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rosini</surname>
<given-names>Alessandra Monteiro</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/645585"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>J&#xfa;nior</surname>
<given-names>Joed Pires de Lima</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2123136"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Melo</surname>
<given-names>Gabriel Nogueira</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2120164"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bland&#xf3;n</surname>
<given-names>Kelvin Orlando Espinoza</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2120167"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gomes</surname>
<given-names>Angelica Oliveira</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/556073"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ambr&#xf3;sio</surname>
<given-names>Sergio Ricardo</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/523072"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Veneziani</surname>
<given-names>Rodrigo Cassio Sola</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/994826"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bastos</surname>
<given-names>Jairo Kenupp</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/524531"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martins</surname>
<given-names>Carlos Henrique Gomes</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/474883"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferro</surname>
<given-names>Eloisa Am&#xe1;lia Vieira</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/376605"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Barbosa</surname>
<given-names>Bellisa Freitas</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/215665"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Federal University of Uberl&#xe2;ndia</institution>, <addr-line>Uberl&#xe2;ndia</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Laboratory of Biology of Reproduction, Institute of Biomedical Sciences, Federal University of Uberl&#xe2;ndia</institution>, <addr-line>Uberl&#xe2;ndia</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Natural and Biological Sciences, Federal University of Tri&#xe2;ngulo Mineiro</institution>, <addr-line>Uberaba</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Nucleus of Research in Technological and Exact Sciences, University of Franca</institution>, <addr-line>Franca</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>School of Pharmaceutical Sciences of Ribeir&#xe3;o Preto, University of S&#xe3;o Paulo</institution>, <addr-line>Ribeir&#xe3;o Preto</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Laboratory of Antimicrobial Testing, Institute of Biomedical Sciences, Federal University of Uberl&#xe2;ndia</institution>, <addr-line>Uberl&#xe2;ndia</addr-line>, <country>Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Mariana De Niz, Universidade de Lisboa, Portugal</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Paula Mello De Luca, Oswaldo Cruz Foundation (FIOCRUZ), Brazil; Shuai Wang, Xinxiang Medical University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Bellisa Freitas Barbosa, <email xlink:href="mailto:bellisafb@ufu.br">bellisafb@ufu.br</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Parasite and Host, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>02</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1113896</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Mart&#xed;nez, Teixeira, de Souza, Rosini, J&#xfa;nior, Melo, Bland&#xf3;n, Gomes, Ambr&#xf3;sio, Veneziani, Bastos, Martins, Ferro and Barbosa</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Mart&#xed;nez, Teixeira, de Souza, Rosini, J&#xfa;nior, Melo, Bland&#xf3;n, Gomes, Ambr&#xf3;sio, Veneziani, Bastos, Martins, Ferro and Barbosa</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The conventional treatment of congenital toxoplasmosis is mainly based on the combination of sulfadiazine and pyrimethamine. However, therapy with these drugs is associated with severe side effects and resistance, requiring the study of new therapeutic strategies. There are currently many studies with natural products, including <italic>Copaifera</italic> oleoresin, showing actions against some pathogens, as <italic>Trypanosoma cruzi</italic> and <italic>Leishmania</italic>. In the present study, we investigated the effects of the leaf hydroalcoholic extract and oleoresin from <italic>Copaifera multijuga</italic> against <italic>Toxoplasma gondii</italic> in human villous (BeWo) and extravillous (HTR8/SVneo) trophoblast cells, as well as in human villous explants from third-trimester pregnancy. For this purpose, both cells and villous explants were infected or not with <italic>T. gondii</italic>, treated with hydroalcoholic extract or oleoresin from <italic>C. multijuga</italic> and analyzed for toxicity, parasite proliferation, cytokine and ROS production. In parallel, both cells were infected by tachyzoites pretreated with hydroalcoholic extract or oleoresin, and adhesion, invasion and replication of the parasite were observed. Our results showed that the extract and oleoresin did not trigger toxicity in small concentrations and were able to reduce the <italic>T. gondii</italic> intracellular proliferation in cells previously infected. Also, the hydroalcoholic extract and oleoresin demonstrated an irreversible antiparasitic action in BeWo and HTR8/SVneo cells. Next, adhesion, invasion and replication of <italic>T. gondii</italic> were dampened when BeWo or HTR8/SVneo cells were infected with pretreated tachyzoites. Finally, infected and treated BeWo cells upregulated IL-6 and downmodulated IL-8, while HTR8/SVneo cells did not change significantly these cytokines when infected and treated. Finally, both the extract and oleoresin reduced the <italic>T. gondii</italic> proliferation in human explants, and no significant changes were observed in relation to cytokine production. Thus, compounds from <italic>C. multijuga</italic> presented different antiparasitic activities that were dependent on the experimental model, being the direct action on tachyzoites a common mechanism operating in both cells and villi. Considering all these parameters, the hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> can be a target for the establishment of new therapeutic strategy for congenital toxoplasmosis.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Toxoplasma gondii</italic>
</kwd>
<kwd>congenital toxoplasmosis (CT)</kwd>
<kwd>trophoblast</kwd>
<kwd>
<italic>Copaifera multijuga</italic>
</kwd>
<kwd>hydroalcoholic extract</kwd>
<kwd>oleoresin</kwd>
</kwd-group>
<contract-num rid="cn002">APQ-01629-22</contract-num>
<contract-num rid="cn003">2017/02858-3</contract-num>
<contract-num rid="cn004">Finance Code 001</contract-num>
<contract-sponsor id="cn001">Conselho Nacional de Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico<named-content content-type="fundref-id">10.13039/501100003593</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de Minas Gerais<named-content content-type="fundref-id">10.13039/501100004901</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de So Paulo<named-content content-type="fundref-id">10.13039/501100001807</named-content>
</contract-sponsor>
<contract-sponsor id="cn004">Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de N&#xed;vel Superior<named-content content-type="fundref-id">10.13039/501100002322</named-content>
</contract-sponsor>
<counts>
<fig-count count="10"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="66"/>
<page-count count="20"/>
<word-count count="11006"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>
<italic>Toxoplasma gondii</italic> is an obligate intracellular protozoan parasite belonging to the Apicomplexa phylum, responsible for serious morbidities mainly related to newborns and immunocompromised people (<xref ref-type="bibr" rid="B8">Blader et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B66">Zhang et&#xa0;al., 2019</xref>). It is estimated that a third of the world population is infected with this microorganism, making it one of the most successful microorganisms (<xref ref-type="bibr" rid="B38">Montoya and Liesenfeld, 2004</xref>). Congenital toxoplasmosis is considered as one of the most serious forms of the disease, caused by the transplacental passage of <italic>T. gondii</italic> tachyzoites acquired during or just before pregnancy. It triggers serious implications for the fetal development and may go unreported into adolescence or adulthood (<xref ref-type="bibr" rid="B34">Kodjikian, 2010</xref>). Primary infection during pregnancy can lead to spontaneous abortion, stillbirth, premature delivery, malformations and neurological or ocular disorders in newborns (<xref ref-type="bibr" rid="B12">Carlier et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B44">Oz, 2014</xref>).</p>
<p>An immune response, preferentially T helper 1 (Th1), is induced when the parasites invade the host cells, requiring components of the innate and adaptive immune response (<xref ref-type="bibr" rid="B13">Carruthers, 2002</xref>). Initially, <italic>T. gondii</italic> is recognized by innate immune response cells, which stimulate interleukin (IL)-12 release by dendritic cells, macrophages and neutrophils, and induce interferon (IFN)-&#x3b3; production by natural killer (NK) cells (<xref ref-type="bibr" rid="B24">Fitch et&#xa0;al., 1975</xref>). The production of these proinflammatory cytokines is associated with the activation of the adaptive immune response mediated by CD4<sup>+</sup> and CD8<sup>+</sup> T cells, which produce high levels of IFN-&#x3b3; as well as other proinflammatory cytokines, besides triggering the release of various inflammatory mediators, such as nitric oxide (NO) by macrophages (<xref ref-type="bibr" rid="B11">Buzoni-Gatel et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B36">Miller et&#xa0;al., 2009</xref>). In addition to IFN-&#x3b3; and IL-12, other proinflammatory cytokines are of great importance in controlling <italic>T. gondii</italic> infection, such as IL-6 and macrophage migration inhibitory factor (MIF) (<xref ref-type="bibr" rid="B16">Castro et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B59">Souza et&#xa0;al., 2021</xref>). Therefore, the production of these proinflammatory cytokines stands out as a robust and classic defense mechanism against <italic>T. gondii</italic> infection in the host. In parallel, IL-8 has been considered an important cytokine during <italic>T. gondii</italic> infection. This cytokine is a member of the CXC chemokine family and it is an important mediator during innate immune response to several pathogens (<xref ref-type="bibr" rid="B21">Dong and Zheng, 2015</xref>). Studies showed that <italic>T. gondii</italic> has the ability to attract IL-8 and this cytokine can recruit inflammatory cells to local infection, attracting neutrophil and immature dendritic cells and, consequently, promoting a dissemination of the infection by host organism (<xref ref-type="bibr" rid="B56">Sommerville et&#xa0;al., 2013</xref>). Then, IL-8 can be an important mediator to favor the establishment of the infection. In addition, anti-inflammatory cytokines such as IL-10 and transforming growth factor (TGF)-&#x3b2; are necessary to prevent an exacerbated immune response that could be detrimental to the host (<xref ref-type="bibr" rid="B25">Fowler et&#xa0;al., 1976</xref>). The immune response is not sufficient to clear the infection. In this sense, the establishment of new drugs are mandatory for infected pregnant women and congenitally infected children.</p>
<p>When maternal infection is present, but without evidence of fetal infection, the classical therapy is based in spiramycin, a macrolide antibiotic that prevents congenital transmission (<xref ref-type="bibr" rid="B23">Elsheikha, 2008</xref>; <xref ref-type="bibr" rid="B60">Tamaru et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B46">Peyron et&#xa0;al., 2017</xref>). In the case of confirmed fetal infection, the first treatment option is the combination of pyrimethamine and sulfadiazine (<xref ref-type="bibr" rid="B65">Villena et&#xa0;al., 1998</xref>; <xref ref-type="bibr" rid="B20">Doliwa et&#xa0;al., 2013</xref>). The coadministration of folinic acid becomes necessary to minimize the toxic effects of pyrimethamine (<xref ref-type="bibr" rid="B39">Montoya and Remington, 2008</xref>). It should be noted that sulfadiazine is associated with gastrointestinal disturbances, and patients often do not tolerate this chemotherapy (<xref ref-type="bibr" rid="B39">Montoya and Remington, 2008</xref>). Furthermore, approximately half of the patients treated with spiramycin retained <italic>Toxoplasma</italic> DNA in their blood for a long time (<xref ref-type="bibr" rid="B27">Habib, 2008</xref>). Therefore, finding active and less toxic drugs as new therapeutic strategies to prevent or treat congenital toxoplasmosis is absolutely necessary and encouraging. Our previous studies have shown alternative drugs or potential molecular targets with great effects against <italic>T. gondii</italic> infection (<xref ref-type="bibr" rid="B18">Costa et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B59">Souza et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B62">Teixeira et&#xa0;al., 2021</xref>). Thus, it is important to highlight the importance of studying alternative treatments for the control of <italic>T. gondii</italic> infection.</p>
<p>In this scenario, the use of natural products and their isolated molecules has emerged as an interesting tool for the discovery of new relevant substances with a great antiparasitic action against <italic>T. gondii.</italic> <xref ref-type="bibr" rid="B30">Huang et&#xa0;al. (2021)</xref> used five essential oleoresins (EOs) and evaluated their antiparasitic activity against <italic>T. gondii</italic> in fibroblast cells (HFF). EOs from <italic>Eucalyptus globulus</italic>, <italic>Cupressus sempervirens</italic>, <italic>Citrus aurantifolia</italic> and <italic>Melaleuca alternifolia</italic> did not show any effect in <italic>T. gondii</italic> infection. However, EO from <italic>Pelargonium X. Asperum</italic> (PaEO) inhibited the growth of <italic>T. gondii</italic> in a dose-dependent manner. Also, another study conducted by <xref ref-type="bibr" rid="B54">Sharif et&#xa0;al. (2019)</xref> evaluated the effect of the hydroalcoholic extract from the stem of <italic>Tinospora crispa</italic> (EETC) against <italic>T. gondii</italic> using Vero cells. The authors observed that EETC induced more than 70% and 80% reduction in invasion rate and parasite intracellular proliferation, respectively. In addition, <xref ref-type="bibr" rid="B37">Miranda et&#xa0;al. (2021)</xref> investigated the action of the hydroalcoholic extract of <italic>Annona muricata</italic> (EtOHAm) and its fractions in the control of <italic>T. gondii</italic>, showing that the HexAm, CH2Cl2Am and EtOAcAm fractions exerted anti-<italic>Toxoplasma</italic> effect <italic>in vitro</italic>; however, only EtOHAm was effective in improving survival and decreasing tissue parasitism in C57BL/6 mice.</p>
<p>
<italic>Copaifera</italic> genus, also popularly known as &#x201c;pau d&#x2019;oleo&#x201d;, belongs to the Fabaceae family (Leguminosae). The representative species of this genus are found mainly in the American and African continents (<xref ref-type="bibr" rid="B64">Veiga-J&#xfa;nior and Pinto, 2002</xref>). <italic>Copaifera</italic> oleoresin is a natural substance composed of a non-volatile solid resinous part formed by diterpenic acids responsible for 55 to 60% of its constitution, which is diluted in another volatile part, the essential oleoresin composed of sesquiterpenes (<xref ref-type="bibr" rid="B14">Cascon and Gilbert, 2000</xref>). <italic>Copaifera</italic> oleoresin has sesquiterpenes, diterpenes and &#x3b2;-caryophyllene as its main compound, possessing healing and antiseptic properties, in addition to being considered as anti-inflammatory and antibiotic (<xref ref-type="bibr" rid="B53">Santos et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B58">Souza et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B5">Arruda et&#xa0;al., 2019</xref>). Several studies have demonstrated the antiparasitic action of the oleoresin and isolated components from <italic>Copaifera</italic> or other members from the Fabaceae family, especially with trypanocidal, leishmanicidal and antiplasmodial activities, through direct action on parasites and/or by modulating the immune response (<xref ref-type="bibr" rid="B31">Izumi et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B63">Tomani et&#xa0;al., 2021</xref>). Extracts and purified molecules of various species of the genera <italic>Piper</italic>, <italic>Tanacetum</italic>, <italic>Porophyllum</italic> and <italic>Copaifera</italic> exhibited interesting antitrypanosomal and antileishmanial activities. These natural compounds affected different structures in the parasites, suggesting that the mitochondria are the strategic target to induce parasite death (<xref ref-type="bibr" rid="B35">Lazarin-Bid&#xf3;ia et&#xa0;al., 2022</xref>).</p>
<p>However, few studies have addressed the action of these compounds against <italic>T. gondii.</italic> Recently, <xref ref-type="bibr" rid="B61">Teixeira et&#xa0;al. (2020)</xref> demonstrated the ability of four <italic>Copaifera</italic> oleoresins (<italic>C. reticulata, C. duckei, C</italic>. <italic>paupera</italic> and <italic>C. pubiflora</italic>) to impair <italic>T. gondii</italic> infection in human villous trophoblast cells (BeWo lineage) and human villous explants from third-trimester pregnancy. However, there are no studies about the possible effects of the hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> against <italic>T. gondii</italic> infection in maternal-fetal interface. <italic>C. multijuga</italic> is found in the Amazon and is now being studied extensively due to its various properties, the most expressive being its anti-inflammatory, anticancer and antimicrobial (antiseptic) properties (<xref ref-type="bibr" rid="B49">Pinheiro et&#xa0;al., 2017</xref>).</p>
<p>In this sense, the present study aims to demonstrate, for the first time, the anti-<italic>T. gondii</italic> effects of the leaf hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> in human trophoblast cells. As experimental models, we used BeWo and HTR8/SVneo cells, representatives of human villous and extravillous trophoblasts, respectively, as well as human villous explants as an experimental model of maternal-fetal interface. Our research group widely uses these cells and explants in studies about human maternal-fetal interface (<xref ref-type="bibr" rid="B7">Barbosa et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B6">Barbosa et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B61">Teixeira et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B59">Souza et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B62">Teixeira et&#xa0;al., 2021</xref>).</p>
</sec>
<sec id="s2" sec-type="material|methods">
<title>Material and methods</title>
<sec id="s2_1">
<title>Cell culture</title>
<p>BeWo cells were commercially obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA), while HTR8/SVneo cells were a gift from Dr. Estela Bevilacqua (University of S&#xe3;o Paulo, S&#xe3;o Paulo, SP, Brazil). Both cells were cultured in RPMI 1640 medium (Cultilab, Campinas, SP, Brazil) supplemented with 100 U/mL penicillin (Sigma Chemical Co., St. Louis, MO, USA), 100 &#x3bc;g/mL streptomycin (Sigma) and 10% fetal bovine serum (FBS) (Cultilab) at 37&#xb0;C and 5% CO<sub>2</sub>.</p>
</sec>
<sec id="s2_2">
<title>Human chorionic villous explant culture</title>
<p>Human third-trimester placentas (36 to 40 weeks of pregnancy), n = 4, were collected after elective cesarean deliveries at the Clinics Hospital of the Federal University of Uberl&#xe2;ndia (HC-UFU), MG, Brazil. Placental tissues were collected based on exclusion criteria, as follows: pre-eclampsia, chronic hypertension, infectious diseases including toxoplasmosis, chorioamnionitis, chronic kidney disease, heart disease, connective tissue disease, pre-existing diabetes mellitus, gestational diabetes mellitus and other pathological manifestations. Briefly, placental tissues were washed in sterile PBS to remove excess blood, then aseptically dissected to remove endometrial tissue and fetal membranes up to 1&#xa0;h after collection. Terminal chorionic villi containing five to seven free tips per explant were harvested and added to 96-well microplates (one villus per well) in 200 &#xb5;L/well of fresh RPMI 1640 medium supplemented with 100 U/mL penicillin, 100 &#xb5;g/mL streptomycin and 10% FBS for 24&#xa0;h at 37&#xb0;C in a humidified atmosphere containing CO<sub>2</sub> (5%) (<xref ref-type="bibr" rid="B55">Silva et&#xa0;al., 2017</xref>).</p>
</sec>
<sec id="s2_3">
<title>Parasite culture</title>
<p>
<italic>Toxoplasma gondii</italic> tachyzoites (2F1 clone) constitutively expressing the &#x3b2;-galactosidase gene were maintained by serial passages in BeWo cells cultured in medium containing 2% FBS, 100 U/mL penicillin and 100 &#x3bc;g/mL streptomycin at 37&#xb0;C and 5% CO<sub>2</sub>. 2F1 clone is derived from the highly virulent strain RH and was a gift from Dr. Vern Carruthers, School of Medicine from the University of Michigan (USA).</p>
</sec>
<sec id="s2_4">
<title>Oleoresin and leaf hydroalcoholic extract from <italic>C. multijuga</italic>
</title>
<p>The samples of oleoresin and leaf hydroalcoholic extract from <italic>C. multijuga</italic> were provided by Professor Carlos Henrique Gomes Martins from the Department of Microbiology (DEMIC), Institute of Biomedical Sciences (ICBIM), Federal University of Uberl&#xe2;ndia (UFU), Uberl&#xe2;ndia, MG, Brazil. Authorization to carry out scientific studies with plant species from the Brazilian biodiversity was requested from the Council for Authorization and Information on Biodiversity (SIBIO/ICMBio/MMA/BRAZIL) and Genetic Heritage Management (CGEN/MMA/BRAZIL). Authorizations to carry out research activities with these plants were issued under numbers 35143-1 and 010225/2014-5, respectively.</p>
<p>Authentic oleoresin was collected in the North region, in the state of Amazonas, in the city of Manacapuru, by Jonas J. M. da Silva by drilling the tree trunks using a 2&#x201d; drill bit. The exudates removed were stored in glass bottles. All the plant material collected was identified by Silvane Tavares Rodrigues, a voucher specimen (NID 03/2013 and 62/2013) was deposited in the Herbarium of the Brazilian Agricultural Research Corporation (Embrapa Eastern Amazon), by direct comparison with authentic herbarium vouchers, of which a taxonomic identity certificate is available upon request.</p>
<p>Air dried leaves (40 &#xb0;C for 48&#xa0;h) of <italic>C. multijuga</italic> (200<italic>&#xa0;g</italic>) were grounded and then exhaustively extracted by maceration with 1.2 L of ethanol/H<sub>2</sub>O (7:3) at room temperature for 48&#xa0;h to afford 50&#xa0;g of <italic>C. multijuga</italic> hydroalcoholic extract of leaves after lyophilization (<xref ref-type="bibr" rid="B48">Pimenta et&#xa0;al., 2019</xref>).</p>
</sec>
<sec id="s2_5">
<title>Cell viability after treatment with oleoresin or hydroalcoholic extract from <italic>C. multijuga</italic>
</title>
<p>We verified the toxicity of the compounds selected in BeWo and HTR8/SVneo cells. For this purpose, we performed the MTT [(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltertrazolin bromide)] colorimetric assay, following the protocol described by <xref ref-type="bibr" rid="B41">Mosmann (1983)</xref>. BeWo (3&#xd7;10<sup>4</sup> cells/well/200 &#xb5;L) and HTR8/SVneo (1.5&#xd7;10<sup>4</sup> cells/well/200 &#xb5;L) cells were cultured in 96-well plates for 24&#xa0;h in RPMI 1640 medium with 10% FBS at 37&#xb0;C and 5% CO<sub>2</sub>. Next, cells were treated in serial dilutions with increasing concentrations of oleoresin or hydroalcoholic extract from <italic>C. multijuga</italic> in a medium with 10% FBS for 24&#xa0;h. In parallel, both cells were treated with DMSO (0.8%), the percentage used to obtain higher dilution for both oleoresin and hydroalcoholic extract. As control, cells were not treated and received only medium. Then, the supernatants were removed and the cells incubated with 10 &#xb5;L MTT (5 mg/mL) plus 90 &#xb5;L of RPMI 10% FBS medium for 4&#xa0;h at 37&#xb0;C and 5% CO<sub>2</sub>. Formazan crystals resulting from cellular metabolism were solubilized by adding a solution containing 10% sodium dodecyl sulfate (SDS, Sigma) and 50% N,N-dimethyl formamide (Sigma) for 30&#xa0;min (<xref ref-type="bibr" rid="B41">Mosmann, 1983</xref>). Optical densities were measured at 570 nm on a plate reader (Versa Max ELISA Microplate Reader, Molecular Devices, Sunnyvale, CA, USA). Data were expressed as the percentage of viable cells (cell viability %) in comparison to untreated cells (100% of cell viability). Three independent experiments were performed in eight replicates.</p>
</sec>
<sec id="s2_6">
<title>
<italic>T. gondii</italic> intracellular proliferation after treatment with oleoresin or hydroalcoholic extract from <italic>C. multijuga</italic>
</title>
<p>We selected different concentrations of oleoresin and hydroalcoholic extract from <italic>C. multijuga</italic> after MTT assay and tested their effect on <italic>T. gondii</italic> growth. BeWo (3&#xd7;10<sup>4</sup> cells/well/200 &#xb5;L) and HTR8/SVneo (1.5&#xd7;10<sup>4</sup> cells/well/200 &#xb5;L) cells were cultured in 96-well plates for 24&#xa0;h in RPMI 1640 medium with 10% FBS at 37&#xb0;C and 5% CO<sub>2</sub>. Next, both cells were infected with <italic>T. gondii</italic> tachyzoites at a multiplicity of infection (MOI) of 3:1 (parasites per cell). After 3&#xa0;h, the medium was discarded, extracellular parasites were retired by washing with medium, and the cells were treated with non-toxic concentrations of oleoresins or hydroalcoholic extracts from <italic>C. multijuga</italic> for additional 24&#xa0;h at 37&#xb0;C and 5% CO<sub>2</sub> as follows: for BeWo cells, 4 to 32 &#xb5;g/mL; for HTR8/SVneo, 4 to 16 &#xb5;g/mL. Sulfadiazine and pyrimethamine (SDZ + PYR, 200 + 8 &#xb5;g/mL for BeWo, and 100 + 4 &#xb5;g/mL for HTR8/SVneo) was used as positive control (<xref ref-type="bibr" rid="B55">Silva et&#xa0;al., 2017</xref>). BeWo or HTR8/SVneo cells infected by <italic>T. gondii</italic> and non-treated were used as negative controls. After 24&#xa0;h of treatment, the culture supernatants were collected and stored at -80&#xb0;C for further measurement of cytokines. In parallel, <italic>T gondii</italic> intracellular proliferation was analyzed using a colorimetric &#x3b2;-galactosidase assay (<xref ref-type="bibr" rid="B55">Silva et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B59">Souza et&#xa0;al., 2021</xref>). We quantified <italic>T. gondii</italic> intracellular proliferation and calculated the number of tachyzoites in comparison with a standard curve containing free tachyzoites (1&#xd7;10<sup>6</sup> to 15,625&#xd7;10<sup>3</sup> parasites). Infected BeWo or HTR8/SVneo cells treated only with medium (negative control) represented uninhibited parasite growth. We calculated the means of untreated cells (medium) that corresponded to 100% of <italic>T. gondii</italic> proliferation. Then, all values about number of tachyzoites obtained from all treatments were compared to 100%, and data demonstrated in % of <italic>T. gondii</italic> proliferation. Three independent experiments were performed in eight replicates.</p>
</sec>
<sec id="s2_7">
<title>Reversibility and reinfection assays</title>
<p>In order to evaluate the maintenance of the antiparasitic effects of oleoresins and hydroalcoholic extracts in <italic>T. gondii</italic> growth, we firstly performed the reversibility test (<xref ref-type="bibr" rid="B61">Teixeira et&#xa0;al., 2020</xref>). Briefly, BeWo (3&#xd7;10<sup>4</sup> cells/well/200 &#xb5;L) or HTR8/SVneo (1.5&#xd7;10<sup>4</sup> cells/well/200 &#xb5;L) cells were seeded in 96-well plates as above described. After 24&#xa0;h in culture, cells were infected with <italic>T. gondii</italic> tachyzoites (3:1) for 3&#xa0;h, washed to remove extracellular parasites and treated for two conditions as follows: (1) BeWo cells were treated with oleoresin or hydroalcoholic extract (both 16 or 32 &#xb5;g/mL), HTR8/SVneo cells were treated with oleoresin or hydroalcoholic extract (both 8 or 16 &#xb5;g/mL), or both cells received SDZ + PYR (positive control) or only medium (negative control), then parasite intracellular proliferation was performed after 24&#xa0;h in culture conditions; (2) cells and parasites were cultured in the same conditions as previously described, but after 24&#xa0;h of treatment, the cells were washed, the medium replaced by new RPMI 1640 medium without treatments, and the parasites were allowed to grow for additional 24&#xa0;h. In both situations, we quantified the <italic>T. gondii</italic> proliferation using the &#x3b2;-galactosidase assay as mentioned above. Finally, we measured the percentage reversibility rate (treatment reversibility %) at 24&#xa0;h after treatment removal compared to the untreated group (considered as 100% reversibility) and the corresponding treatment condition at 24&#xa0;h of treatment (baseline for comparison). Three independent experiments were performed in eight replicates.</p>
<p>To corroborate the reversibility data, we investigated whether the treatment with oleoresin or hydroalcoholic extract in infected BeWo and HTR8/SVneo cells would interfere with the ability of these parasites to invade and replicate within new fresh cells. Briefly, BeWo and HTR8/SVneo cells were seeded at 1.0x10<sup>6</sup> cells/well in 6-well plates. After 24&#xa0;h, cells were infected with <italic>T. gondii</italic> tachyzoites (3:1) for 3&#xa0;h at 37&#xb0;C and 5% CO<sub>2</sub>. Then, we treated the cells with oleoresin or hydroalcoholic extract at 16 or 32 &#xb5;g/mL for BeWo; or 8 or 16 &#xb5;g/mL for HTR8/SVneo. Either SDZ + PYR or only medium was added as controls. After 24&#xa0;h, we collected the intracellular parasites from infected cells by multiple passages through a 21- and 26-gauge needle. Finally, <italic>T. gondii</italic> tachyzoites from each experimental condition were then allowed to reinfect previously seeded BeWo (3&#xd7;10<sup>4</sup> cells/well/200 &#xb5;L) and HTR8/SVneo (1.5&#xd7;10<sup>4</sup> cells/well/200 &#xb5;L) cells monolayers in 96-well plates. The ability to infect the cells was analyzed after 3&#xa0;h, when the &#x3b2;-galactosidase assay was used to quantify the total number of tachyzoites (% of <italic>T. gondii</italic> invasion), as described above. Three independent experiments were performed in eight replicates.</p>
</sec>
<sec id="s2_8">
<title>Adhesion assay of <italic>T. gondii</italic>: pretreated tachyzoites with oleoresin or hydroalcoholic extract</title>
<p>We performed an adherence test (<xref ref-type="bibr" rid="B43">Oliveira et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B9">Borges et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B61">Teixeira et&#xa0;al., 2020</xref>). Cells were seeded at a density of 1.0 &#xd7; 10<sup>5</sup> (BeWo) and 6.0 &#xd7; 10<sup>4</sup> (HTR8/SVneo) in 24-well plates containing 13-mm coverslips in each well. Cells were fixed with paraformaldehyde (4%) for 30&#xa0;min. They were then washed three times with 1x phosphate buffered saline (PBS). Subsequently, <italic>T. gondii</italic> tachyzoites were preincubated for 1&#xa0;h with oleoresin, hydroalcoholic extract or SDZ + PYR. Pretreated tachyzoites with 16 or 32 &#xb5;g/ml of oleoresin or hydroalcoholic extract were used to adhere BeWo cells; while preincubated parasites with 8 or 16 &#xb5;g/ml of oleoresin or hydroalcoholic extract were used to adhere HTR8/SVneo cells. SDZ + PYR (200 + 8 &#x3bc;g/mL for later adhesion in BeWo, or 100 + 4 &#x3bc;g/mL for later adhesion in HTR8/SVneo), or only medium, were used as controls. Pretreated tachyzoites by 1&#xa0;h, as described, were resuspended in medium and incubated with fixed cells for 3&#xa0;h. Subsequently, the coverslips were incubated overnight with mouse anti-<italic>T. gondii</italic> monoclonal primary antibody [SAG1/p30] (Abcam TP3 #ab8313) (diluted 1:500 in PGN-0.01% saponin solution). Coverslips were then rinsed three times with 1x PBS and incubated with Alexa Fluor 488 conjugated anti-mouse IgG (Invitrogen, USA #A11001) (diluted 1:500 in PGN-0.01% saponin solution), phalloidin conjugated with tetramethylrhodamine isothiocyanate (TRITC) (Sigma, P1951) (diluted 1:50 in PGN+saponin) and TOPRO-3 Iodide (Life Techonologies) (diluted 1:500 in PGN+saponin) for 1&#xa0;h in the dark at room temperature to label tachyzoites, F-actin and nuclei, respectively. We mounted coverslips on glass slides and samples were analyzed by confocal fluorescence microscopy (Zeiss, LSM 510 Meta, Germany) with an inverted microscope (Zeiss Axiovert 200 M). We analyzed the following parameters: the number of BeWo and HTR8/SVneo cells with adhered tachyzoites and the total number of adhered tachyzoites per cell in a total of 20 randomly chosen fields. Two independent experiments were performed in three replicates.</p>
</sec>
<sec id="s2_9">
<title>Invasion and <italic>T. gondii</italic> intracellular proliferation in cells infected with pretreated tachyzoites with oleoresin or hydroalcoholic extract from <italic>C. multijuga</italic>
</title>
<p>After checking the adhesion of pretreated parasites on BeWo and HTR8/SVneo cells, we also investigated the intracellular replication and invasion of pretreated parasites with oleoresins or hydroalcoholic extract (<xref ref-type="bibr" rid="B15">Castanheira et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B61">Teixeira et&#xa0;al., 2020</xref>). Then, <italic>T. gondii</italic> tachyzoites were preincubated for 1&#xa0;h at 37&#xb0;C and 5% CO<sub>2</sub> with oleoresin or ethanol extract (32 or 16 &#xb5;g/mL for later infection in BeWo, or 16 or 8 &#xb5;g/mL for later infection in HTR8/SVneo). In parallel, tachyzoites were also treated with SDZ + PYR (200 + 8 &#x3bc;g/mL for later infection in BeWo, or 100 + 4 &#x3bc;g/mL for later infection in HTR8/SVneo), or only medium. Subsequently, the pretreated parasites were added in previously adhered BeWo or HTR8/SVneo cells in 96-well plates. Finally, two different analyses were performed: (1) to verify the <italic>T. gondii</italic> invasion, both cells were maintained with pretreated tachyzoites for only 3&#xa0;h; or (2) to verify parasite intracellular proliferation, the cell monolayers were washed after 3&#xa0;h of infection, a fresh supplemented culture medium was added, and the culture maintained for another 24&#xa0;h at 37&#xb0;C and 5% CO<sub>2</sub>. In both experiments, intracellular <italic>T. gondii</italic> was quantified using the &#x3b2;-galactosidase assay, as described above (<xref ref-type="bibr" rid="B55">Silva et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B59">Souza et&#xa0;al., 2021</xref>). Three independent experiments were performed in eight replicates.</p>
</sec>
<sec id="s2_10">
<title>Viability of human villous explants treated with oleoresin or hydroalcoholic extract</title>
<p>Toxicity of oleoresin and hydroalcoholic extract in human villous explants was performed using viability assays with lactate dehydrogenase (LDH) and MTT, according to previous protocols (<xref ref-type="bibr" rid="B61">Teixeira et&#xa0;al., 2020</xref>). In both assays, explants were treated with oleoresin or hydroalcoholic extract from <italic>C. multijuga</italic> at 64, 128 or 256 &#xb5;g/mL or SDZ + PYR (150 + 200 &#xb5;g/mL) (<xref ref-type="bibr" rid="B55">Silva et&#xa0;al., 2017</xref>). As viability control, explants were treated with culture medium alone. After 24&#xa0;h of incubation, the culture supernatants were collected and LDH concentration measured according to the manufacturer&#x2019;s instructions (<xref ref-type="bibr" rid="B17">Castro-Filice et&#xa0;al., 2014</xref>), with minor modifications (LDH Liquiform, Labtest Diagnostica S.A., Lagoa Santa, MG, Brazil). This assay is based on the consumption and decreased absorption of NADH at 340 nm, measured by a microplate reader (Versa Max ELISA Microplate Reader, Molecular Devices, Sunnyvale, CA, USA). LDH released in the culture the medium was expressed in U/L of LDH enzymatic activity and was used as a marker of tissue integrity. In parallel, in the same experimental condition, as described above, the viability of the tissue was also evaluated by the MTT test (<xref ref-type="bibr" rid="B61">Teixeira et&#xa0;al., 2020</xref>). Tissue viability was expressed in percentages (% viability by MTT incorporation), and the absorbance of villi incubated with culture medium alone (untreated villous explants) was considered to be 100% viable. In addition, we performed a morphological analysis of the treated explants. Tissue sections were included in paraffin, stained with hematoxylin/eosin and examined under a light microscope (BX40 Olympus, Tokyo, Japan). Two independent experiments were performed in six replicates.</p>
</sec>
<sec id="s2_11">
<title>
<italic>T. gondii</italic> infection in human villous explants treated with oleoresin or hydroalcoholic extract</title>
<p>Also, we quantified the <italic>T. gondii</italic> intracellular proliferation in explants treated with oleoresin or hydroalcoholic extract from <italic>C. multijuga</italic> using the &#x3b2;-galactosidase colorimetric assay (<xref ref-type="bibr" rid="B55">Silva et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B59">Souza et&#xa0;al., 2021</xref>), with minor modifications. Explants were cultured in 96-well microplates (one villus per well/200 &#xb5;l) in supplemented culture medium for 24&#xa0;h at 37&#xb0;C and 5% CO<sub>2</sub>. Then, the villi were infected with <italic>T. gondii</italic> tachyzoites (1 &#xd7; 10<sup>6</sup> parasites per well/200 &#xb5;L) and incubated for 24&#xa0;h at 37&#xb0;C and 5% CO<sub>2</sub>. Subsequently, the villous explants were thoroughly rinsed with culture medium to remove non-adherent parasites. Following our tissue viability data (LDH and MTT assays), the villi were treated for additional 24&#xa0;h with oleoresin or hydroalcoholic extract (256 and 128 &#xb5;g/mL), or SDZ + PYR (150 + 200 &#xb5;g/mL). Uninfected and untreated or infected and untreated explants were cultured with culture medium alone. Finally, the culture supernatants were collected and stored at -80&#xb0;C for future cytokine measurement. In addition, the villous explants were collected and stored at &#x2212;80&#xb0;C for the following analyses: determination of protein content using Bradford reagent and <italic>T. gondii</italic> intracellular proliferation by &#x3b2;-galactosidase assay. Initially, frozen villous explants were homogenized by the addition of 150 &#xb5;L of radioimmunoprecipitation assay buffer (RIPA) [50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 1% (w/v) sodium deoxycholate and 0.1% (w/v) sodium deoxycholate SDS, pH 7.5] containing protease inhibitor cocktail (Complete, Roche Diagnostic, Mannheim, Germany). Homogenate was centrifuged at 21,000 &#xd7; g for 15&#xa0;min at 4&#xb0;C, and the supernatant was collected to measure the total amount of protein using the Bradford method (<xref ref-type="bibr" rid="B10">Bradford, 1976</xref>). <italic>T. gondii</italic> intracellular proliferation was carried out with 20 &#xb5;L of supernatants from each sample (<xref ref-type="bibr" rid="B61">Teixeira et&#xa0;al., 2020</xref>), absorbance measured at 570 nm using a kinetic plate reader (Versa Max ELISA Microplate Reader, Molecular Devices, Sunnyvale, CA, USA), the number of tachyzoites was normalized according to total protein concentration (&#xb5;g/mL) of each villus obtained by Bradford assay, and expressed by the number of parasites per &#xb5;g of tissue. The data were presented as a percentage (% of <italic>T. gondii</italic> proliferation), as described above. Four independent experiments were performed in six replicates.</p>
</sec>
<sec id="s2_12">
<title>Cytokine measurement</title>
<p>We measured cytokines in supernatants using a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA). ELISA for IL-6, IL-8, TNF, IL-10, and MIF were purchased from OpTEIA, BD Bioscience, San Diego, CA, USA; or Duoset R&amp;D Systems, Minneapolis, MN, USA, and tests were performed according to the manufacturer&#x2019;s instructions. The detection limits of each cytokine were 4.7 pg/mL for IL-6; 31.2 pg/mL for IL-8; 7.8 pg/mL for TNF, IL-10 and MIF.</p>
<p>For villous explants, the data were normalized according to the total protein of each villous. Then, the data about cytokines were obtained by the ratio between concentration of cytokines (pg/mL) and concentration of total protein from Bradford assay (&#xb5;g/mL), resulting in pg/mg of tissue (<xref ref-type="bibr" rid="B55">Silva et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B59">Souza et&#xa0;al., 2021</xref>).</p>
</sec>
<sec id="s2_13">
<title>Measurement of intracellular reactive oxygen species</title>
<p>The influence of oleoresin and hydroalcoholic extract in ROS production was also verified in BeWo and HTR8/SVneo cells. The assay was based on the peroxide-dependent oxidation of 2&#x2019;,7&#x2019;-dichlorodihydrofluorescein diacetate (H2DCF-DA) to form the fluorescent compound 2&#x2019;,7&#x2019;-dichlorofluorescein (DCF), with some modifications. Briefly, BeWo (3&#xd7;10<sup>4</sup> cells/well/200 &#xb5;L) or HTR8/SVneo (1.5&#xd7;10<sup>4</sup> cells/well/200 &#xb5;L) cells were seeded in 96-well black clear-bottom plate. Then, cells were infected or not with <italic>T. gondii</italic> tachyzoites (3:1) for 3&#xa0;h; they were then washed abundantly with culture medium and treated with oleoresin or hydroalcoholic extract (16 or 32 &#xb5;g/mL) for BeWo and (8 or 16 &#xb5;g/mL) for HTR8/SVneo cells, or both cells received SDZ + PYR cells (200 + 8 &#x3bc;g/mL for BeWo, and 100 + 4 &#x3bc;g/mL for HTR8/SVneo) or only medium, as controls. Hydrogen peroxide (H2O2) was used as a positive control for ROS production. After treatment for 24&#xa0;h, cells were harvested, washed with 1&#xd7;PBS and incubated with 150 &#x3bc;L of H2DCF-DA (10 &#x3bc;M; diluted in 1&#xd7;PBS containing 10% FBS) for 45&#xa0;min at 37&#xb0;C and 5% CO2 in the dark. Finally, the DCF fluorescence intensity was detected using a microplate reader (GloMax<sup>&#xae;</sup> Discover System, Promega Corporation) at excitation and emission wavelengths of 488 nm and 522 nm, respectively. The data are presented as median fluorescence intensity (MFI). Three independent experiments were performed in eight replicates.</p>
</sec>
<sec id="s2_14">
<title>Ethics</title>
<p>The present research protocol using human tissue samples was approved by the Ethics Committee of the Federal University of Uberlandia, MG, Brazil, with approval number 3.679.426.&#xa0;A consent term was obtained from all subjects and/or their legal guardians.</p>
</sec>
<sec id="s2_15">
<title>Statistical analysis</title>
<p>All data were expressed as means &#xb1; standard deviations (SD) using GraphPad Prisma version 8.01. Significant differences were compared to controls by using One-way ANOVA, Bonferroni&#x2019;s multiple comparisons post-test for the parametric data. Nonparametric data were analyzed by the Kruskal&#x2013;Wallis test and Tukey&#x2019;s multiple comparison post-test. Data were considered statistically significant when <italic>P</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Leaf hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> altered the cell viability at higher concentrations</title>
<p>Firstly, we evaluated the cell viability in BeWo and HTR8/SVneo&#xa0;cells treated with hydroalcoholic extract or oleoresin in several concentrations.</p>
<p>Reduced cell viability was detected in BeWo cells exposed to hydroalcoholic extract or oleoresin from 64 to 512 &#xb5;g/mL (<sup>*</sup>
<italic>P</italic> &lt; 0.05, <sup>****</sup>
<italic>P</italic> &lt; 0.00001) in comparison to untreated cells (medium) (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A, B</bold>
</xref>). DMSO-treated cells did not show any change in cell viability in relation to untreated cells (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A, B</bold>
</xref>). On the other hand, HTR8/SVneo diminished cell viability when treated with hydroalcoholic extract or oleoresin from 32 (<sup>***</sup>
<italic>P</italic> &lt; 0.0001, <sup>**</sup>
<italic>P</italic> &lt; 0.001) to 512 &#xb5;g/mL (<sup>****</sup>
<italic>P</italic> &lt; 0.00001) when compared to untreated cells (medium) (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1C, D</bold>
</xref>). As observed for BeWo, DMSO also did not induce change in cell viability for HTR8/SVneo (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1C, D</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Cell viability. BeWo <bold>(A, B)</bold> and HTR8/SVneo <bold>(C, D)</bold> cells were treated or not with several concentrations of oleoresin or hydroalcoholic extract from <italic>C. multijuga</italic> for 24&#xa0;h, and MTT assay was performed. Cell viability was expressed as percentage (cell viability %), considering the absorbance of cells incubated only with the medium as 100% viability. The results are expressed as means &#xb1; standard deviation of three independent experiments performed with eight replicates. Significant differences detected by One-Way ANOVA with Bonferroni&#x2019;s multiple comparison post-test, or Kruskal-Wallis when appropriate. <sup>*</sup>
<italic>P</italic> &lt; 0.05, <sup>**</sup>
<italic>P</italic> &lt; 0.001, <sup>***</sup>
<italic>P</italic> &lt; 0.0001, and <sup>****</sup>
<italic>P</italic> &lt; 0.00001 in relation to the medium.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113896-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>Leaf hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> significantly reduced <italic>T. gondii</italic> intracellular proliferation in BeWo and HTR8/SVneo cells</title>
<p>In our cell viability assay, we established concentrations of hydroalcoholic extract and oleoresin that did not alter the viability of BeWo and HTR8/SVneo cells for the subsequent set up of experiments.</p>
<p>Both hydroalcoholic extract and oleoresin reduced significantly the parasite proliferation in BeWo (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>) and HTR8/SVneo (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>) cells in all concentrations tested in comparison to untreated cells (medium) (<sup>***</sup>
<italic>P</italic> &lt; 0.0001; <sup>*****</sup>
<italic>P</italic> &lt; 0.00001). In addition, sulphadiazine and pyrimethamine (SDZ + PYR) also diminished <italic>T. gondii</italic> replication in relation to untreated cells (<sup>****</sup>
<italic>P</italic> &lt; 0.00001). These results demonstrated that both the hydroalcoholic extract and oleoresin had an antiproliferative effect against <italic>T. gondii</italic>.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>
<italic>T. gondii</italic> intracellular proliferation. BeWo <bold>(A)</bold> and HTR8/SVneo <bold>(B)</bold> cells were infected by <italic>T. gondii</italic> and treated or not with non-toxic concentrations of hydroalcoholic extract or oleoresin from <italic>C. multijuga</italic> for 24&#xa0;h. Untreated and infected cells (medium) were considered as 100% parasite proliferation, and SDZ + PYR was used as positive control. <italic>T. gondii</italic> intracellular proliferation was analyzed using a &#x3b2;-galactosidase colorimetric assay and expressed as percentage (% of <italic>T. gondii</italic> proliferation) in comparison to untreated cells (medium). The results were expressed as means &#xb1; standard deviation of three experiments performed in eight replicates. Significant differences detected by One-Way ANOVA, Bonferroni&#x2019;s multiple comparisons post-test. <sup>***</sup>
<italic>P</italic> &lt; 0.0001 or <sup>****</sup>
<italic>P</italic> &lt; 0.00001 in relation to the medium.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113896-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Leaf hydroalcoholic extract and oleoresin exhibited an irreversible antiparasitic effect</title>
<p>In order to determine whether the antiparasitic effects promoted by the hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> would be irreversible, we exposed infected BeWo and HTR8/SVneo cells to the hydroalcoholic extract or oleoresin for 24&#xa0;h, then cell monolayers were rinsed and incubated with medium free of treatment for additional 24&#xa0;h. At the same time, we quantified the parasite proliferation after 24&#xa0;h of treatment as a baseline for comparison. For BeWo cells, we choose 16 and 32 &#xb5;g/mL for both the hydroalcoholic extract and oleoresin; for HTR8/SVneo, 8 and 16 &#xb5;g/mL were the choice.</p>
<p>As previously detected (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>), again both the hydroalcoholic extract and oleoresin reduced <italic>T. gondii</italic> intracellular proliferation after 24&#xa0;h of treatment in BeWo (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>) and HTR8/SVneo cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>) when compared to untreated cells (medium) (<sup>**</sup>
<italic>P</italic> &lt; 0.001, <sup>****</sup>
<italic>P</italic> &lt; 0.00001). Also, SDZ + PYR decreased parasite replication in relation to untreated cells (<sup>****</sup>
<italic>P</italic> &lt; 0.00001) (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>). Interestingly, both the hydroalcoholic extract and oleoresin showed an irreversible effect on tachyzoites, since a reduced parasite growth remained active in BeWo and HTR8/SVneo cells in comparison to untreated cells (considered as 100% reversibility), even after removal of treatments for additional 24&#xa0;h (<sup>****</sup>
<italic>P</italic> &lt; 0.00001) (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>). For both cells, SDZ + PYR also showed irreversible effect (<sup>****</sup>
<italic>P</italic> &lt; 0.00001) (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>). These results suggest that both the hydroalcoholic extract and oleoresin maintained their antiproliferative effect even after the elimination of the treatment.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Reversibility test. BeWo <bold>(A)</bold> and HTR8/SVneo <bold>(B)</bold> cells were infected by <italic>T. gondii</italic> and treated or not with non-toxic concentrations of the hydroalcoholic extract or oleoresin from <italic>C. multijuga</italic> for 24&#xa0;h. In parallel, both cells were infected, treated, washed to remove the treatments, and maintained for additional 24&#xa0;h in the medium free of treatment. Untreated and infected cells (medium) were considered as 100% reversibility of treatment, and SDZ + PYR was used as positive control. <italic>T. gondii</italic> intracellular proliferation was analyzed using a &#x3b2;-galactosidase colorimetric assay and expressed as percentage (reversibility of treatment) in comparison to untreated cells (medium). The reversibility index measured the ability of parasites to recover from treatment and proliferate in new cells. Finally, parasites obtained directly from BeWo <bold>(C)</bold> and HTR8/SVneo <bold>(D)</bold> cells treated with the hydroalcoholic extract or oleoresin were collected and used to infect new cells for 3&#xa0;h. The number of tachyzoites was determined using the &#x3b2;-galactosidase assay and expressed as % of <italic>T. gondii</italic> invasion. The results were expressed as means &#xb1; standard deviation of three experiments performed in eight replicates. Significant differences detected by the One-Way ANOVA, Bonferroni&#x2019;s multiple comparisons post-test. <sup>*</sup>
<italic>P</italic> &lt; 0.05, <sup>**</sup>
<italic>P</italic> &lt; 0.001, <sup>***</sup>
<italic>P</italic> &lt; 0.0001 or <sup>****</sup>
<italic>P</italic> &lt; 0.00001 in relation to the medium. <sup>&amp;</sup>
<italic>P</italic> &lt; 0.05 in relation to SDZ + PYR.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113896-g003.tif"/>
</fig>
<p>In order to obtain more information about the effect triggered by both the hydroalcoholic extract and oleoresin on <italic>T. gondii</italic> tachyzoites, we evaluated whether intracellular parasites obtained directly from treated-BeWo and HTR8/SVneo cells could maintain their ability to infect new host cells. For this purpose, tachyzoites were collected from treated-BeWo and HTR8/SVneo cells and used to infect new monolayer cells. For BeWo cells, all concentrations of hydroalcoholic extract and oleoresin reduced the ability of tachyzoites to infect new BeWo cells when compared to untreated cells (medium) (<sup>***</sup>
<italic>P</italic> &lt; 0.0001; <sup>****</sup>
<italic>P</italic> &lt; 0.00001) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). SDZ + PYR also reduced the ability of parasites to infect new BeWo cells in relation to medium (<sup>****</sup>
<italic>P</italic> &lt; 0.00001) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Although the hydroalcoholic extract and oleoresin have downmodulated the ability of parasites to infect new BeWo cells, this effect was lower if compared to classical treatment (SDZ + PYR) (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Finally, for HTR8/SVneo cells, all treatments (hydroalcoholic extract, oleoresin and SDZ + PYR) dampened the capacity of <italic>T. gondii</italic> to infect new HTR8/SVneo cells in comparison to untreated cells (<sup>*</sup>
<italic>P</italic> &lt; 0.05; <sup>**</sup>
<italic>P</italic> &lt; 0.001; <sup>****</sup>
<italic>P</italic> &lt; 0.00001) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). Interestingly, parasites derived from hydroalcoholic extract-treated-cells at 16 &#xb5;g/mL demonstrated lower ability to infect new cells when compared to SDZ + PYR (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>).</p>
<p>These findings indicate that the inhibitory effects promoted by the hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> dampen the ability of parasites to invade new host cells.</p>
</sec>
<sec id="s3_4">
<title>Pretreatment of <italic>T. gondii</italic> tachyzoites with leaf hydroalcoholic extract and oleoresin altered adhesion, invasion and subsequent intracellular proliferation</title>
<p>To assess whether hydroalcoholic extract and oleoresin have a direct action on tachyzoites, we performed a variety of assays. In the first set of experiments, we evaluated whether the hydroalcoholic extract and oleoresin treatments would affect parasite adhesion to host cells. For this purpose, <italic>T. gondii</italic> tachyzoites were pretreated for 1&#xa0;h with oleoresin or hydroalcoholic extract and then incubated with previously fixed-BeWo or HTR8/SVneo cells.</p>
<p>As result for BeWo cells, only the hydroalcoholic extract or oleoresin at 32 &#xb5;g/mL was able to reduce the number of cells with adhered parasites when compared to untreated parasites (medium) (<sup>***</sup>
<italic>P</italic> &lt; 0.0001, <sup>*</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). On the other hand, all concentrations of treatments, except for SDZ + PYR, reduced the total number of adhered parasites in relation to untreated parasites (<sup>****</sup>
<italic>P</italic> &lt; 0.00001, <sup>**</sup>
<italic>P</italic> &lt; 0.001) and SDZ + PYR-treated parasites (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). Representative images showing the effect of the hydroalcoholic extract and oleoresin on BeWo cells incubated with pretreated-tachyzoites can be observed in <xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4C-F</bold>
</xref>.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Adhesion assay in BeWo cells. <italic>T. gondii</italic> tachyzoites were preincubated for 1&#xa0;h with the hydroalcoholic extract or oleoresin from <italic>C. multijuga</italic>, and then allowed to interact with previously fixed BeWo cells during 3&#xa0;h. As control, tachyzoites were incubated with SDZ + PYR or only medium (medium). The number of cells with adhered parasites <bold>(A)</bold> and the total number of adhered parasites <bold>(B)</bold> were determined in a total of 20 fields examined randomly with 20X objective lens. Representative images highlighting the effect of treatments on the tachyzoite-host cell interaction: <bold>(C)</bold> untreated parasites, <bold>(D)</bold> 32 &#xb5;g/mL hydroalcoholic extract, <bold>(E)</bold> 16 &#xb5;g/mL oleoresin and <bold>(F)</bold> 32 &#xb5;g/mL oleoresin. The results were expressed as means &#xb1; standard deviation of two experiment performed in three replicates. Significant differences detected by One-Way ANOVA and Bonferroni&#x2019;s multiple comparisons post-test. <sup>*</sup>
<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.001, <sup>***</sup>
<italic>P</italic> &lt; 0.0001 or <sup>****</sup>
<italic>P</italic> &lt; 0.00001 in relation to the medium. <sup>&amp;</sup>
<italic>P</italic> &lt; 0.05 in relation to SDZ + PYR. White arrows indicate tachyzoites attached to BeWo cells. The cell nucleus is labeled with TOPRO-3 (blue). <italic>T. gondii</italic> tachyzoites labeled with Alexa Fluor 488-conjugated anti-mouse IgG (green). Phalloidin-TRITC labeled F-actin is shown in red. Scale bar: 50 &#xb5;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113896-g004.tif"/>
</fig>
<p>Similarly, parasites pretreated with the hydroalcoholic extract or oleoresin diminished their ability to adhere in HTR8/SVneo cells, since the number of cells with adhered parasites as well as the total number of adhered parasites per field were significantly smaller when related to untreated parasites (medium) (<sup>****</sup>
<italic>P</italic> &lt; 0.00001) and SDZ + PYR-treated parasites (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A, B</bold>
</xref>). Also, SDZ + PYR reduced the number of cells with adhered parasites (<sup>***</sup>
<italic>P</italic> &lt; 0.0001) and the total number of adhered parasites (<sup>**</sup>
<italic>P</italic> &lt; 0.001) in relation to the medium (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A, B</bold>
</xref>). Representative images showing the effect of the hydroalcoholic extract and oleoresin on HTR8/SVneo cells incubated with pretreated-tachyzoites can be observed in <xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5C-F</bold>
</xref>.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Adhesion assay in HTR8/SVneo cells. <italic>T. gondii</italic> tachyzoites were preincubated for 1&#xa0;h with the hydroalcoholic extract or oleoresin from <italic>C</italic>. <italic>multijuga</italic>, and then allowed to interact with previously fixed HTR8/SVneo cells during 3&#xa0;h. As control, tachyzoites were incubated with SDZ + PYR or only medium (medium). The number of cells with adhered parasites <bold>(A)</bold> and the total number of adhered parasites <bold>(B)</bold> were determined in a total of 20 fields examined randomly with 20X objective lens. Representative images highlighting the effect of the treatments on the tachyzoite-host cell interaction: <bold>(C)</bold> untreated parasites, <bold>(D)</bold> 16 &#xb5;g/mL hydroalcoholic extract, <bold>(E)</bold> 8 &#xb5;g/mL oleoresin, and <bold>(F)</bold> 16 &#xb5;g/mL oleoresin. The results were expressed as means &#xb1; standard deviation of two experiment performed in three replicates. Significant differences detected by One-Way ANOVA and Bonferroni&#x2019;s multiple comparisons post-test. <sup>**</sup>
<italic>P</italic> &lt; 0.001, <sup>***</sup>
<italic>P</italic> &lt; 0.0001 or <sup>****</sup>
<italic>P</italic> &lt; 0.00001 in relation to the medium. <sup>&amp;</sup>
<italic>P</italic> &lt; 0.05 in relation to SDZ + PYR. White arrows indicate tachyzoites attached to HTR8/SVneo cells. The cell nucleus is labeled with TOPRO-3 (blue). <italic>T. gondii</italic> tachyzoites labeled with Alexa Fluor 488-conjugated anti-mouse IgG (green). Phalloidin-TRITC labeled F-actin is shown in red. Scale bar: 50 &#xb5;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113896-g005.tif"/>
</fig>
<p>Considering that pretreated parasites had lower ability to adhere to host cells (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4</bold>
</xref>, <xref ref-type="fig" rid="f5">
<bold>5</bold>
</xref>), we now verified the capacity to invade and proliferate when also preincubated with the hydroalcoholic extract or oleoresin. Our data demonstrated that the pretreatment of <italic>T. gondii</italic> tachyzoites with all the hydroalcoholic extract or oleoresin concentrations triggered low rates of invasion and intracellular proliferation, regardless of the cell type (<sup>***</sup>
<italic>P</italic> &lt; 0.0001, <sup>****</sup>
<italic>P</italic> &lt; 0.00001), in comparison to untreated parasites (medium) (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A-D</bold>
</xref>). SDZ + PYR also reduced the invasion and replication of pretreated tachyzoites in BeWo and HTR8/SVneo cells in relation to the medium (<sup>**</sup>
<italic>P</italic> &lt; 0.001, <sup>***</sup>
<italic>P</italic> &lt; 0.0001, <sup>****</sup>
<italic>P</italic> &lt; 0.00001) (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A-D</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Invasion and proliferation assay. <italic>T. gondii</italic> tachyzoites were preincubated for 1&#xa0;h with the hydroalcoholic extract or oleoresin from <italic>C. multijuga</italic>, and then allowed to interact with BeWo <bold>(A, B)</bold> or HTR8/SVneo <bold>(C, D)</bold> cells during 3 or 24&#xa0;h to verify invasion and intracellular proliferation, respectively. As control, tachyzoites were incubated with SDZ + PYR or only medium (medium). The % of <italic>T. gondii</italic> invasion and the % of <italic>T. gondii</italic> proliferation were determined using the &#x3b2;-galactosidase activity. Untreated parasites (medium) were considered as 100% invasion and proliferation. The results were expressed as means &#xb1; standard deviation of three experiments performed in eight replicates. Significant differences detected by One-Way ANOVA and Bonferroni&#x2019;s multiple comparisons post-test. <sup>**</sup>
<italic>P</italic> &lt; 0.001, <sup>***</sup>
<italic>P</italic> &lt; 0.0001 or <sup>****</sup>
<italic>P</italic> &lt; 0.00001 in relation to the medium.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113896-g006.tif"/>
</fig>
<p>These findings indicate that the hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> dampen the ability of parasites to adhere, invade and proliferate in host cells from maternal-fetal interface.</p>
</sec>
<sec id="s3_5">
<title>Leaf hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> upregulated IL-6 and downmodulated IL-8 in BeWo cells</title>
<p>So far, our findings demonstrated that the hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> have a direct effect on the parasites, since treated parasites have reduced ability to adhere, invade and replicate into the cells. However, we could not exclude the possibility that these compounds may affect the host cell environment. Thus, we investigated the possible immunomodulatory effects of the hydroalcoholic extract and oleoresin by measuring cytokines in culture supernatant.</p>
<p>For BeWo cells, our results showed that in the absence of infection, concentrations of 32 &#xb5;g/mL of the hydroalcoholic extract and oleoresin induced an increase in IL-6 levels in comparison to untreated cells (medium) (<sup>*</sup>
<italic>P</italic> &lt; 0.05, <sup>**</sup>
<italic>P</italic> &lt; 0.001) and SDZ + PYR (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). After <italic>T. gondii</italic> infection, levels of IL-6 were higher in untreated/infected cells (medium Tg) compared to untreated and uninfected cells (medium) (<sup>#</sup>
<italic>P</italic> &lt; 0.05). However, SDZ + PYR reduced IL-6 in relation to untreated/infected cells (<sup>**</sup>
<italic>P</italic> &lt; 0.001). In addition, all concentrations of the hydroalcoholic extract or oleoresin induced an upregulation of IL-6 in infected BeWo cells when compared to SDZ + PYR-treated cells (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05). Also, 32 &#xb5;g/mL of oleoresin induced an increase of IL-6 in comparison to untreated/infected cells (<sup>**</sup>
<italic>P</italic> &lt; 0.001) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Cytokine and ROS production in BeWo cells. BeWo cells were infected and treated or not with the hydroalcoholic extract or oleoresin from <italic>C. multijuga</italic> for 24&#xa0;h. Untreated and uninfected cells (medium), untreated and infected cells (medium Tg) and SDZ + PYR were used as controls. Then, supernatants were collected and used to measure IL-6 <bold>(A, B)</bold>, IL-8 <bold>(C, D)</bold> and MIF <bold>(E, F)</bold>. In parallel, BeWo cells were infected, treated or not with the hydroalcoholic extract or oleoresin from <italic>C. multijuga</italic> for 24&#xa0;h, incubated with the probe 2&#x2032;,7&#x2032;-dichlorodihydrofluorescein diacetate (H2DCF-DA), ROS production was measured by a plate reader and data expressed as mean fluorescence intensity (MFI) <bold>(G, H)</bold>. The results were expressed as means &#xb1; standard deviation of three experiments performed in eight replicates. Significant differences detected by One-Way ANOVA, Bonferroni&#x2019;s multiple comparisons post-test. <sup>*</sup>
<italic>P</italic> &lt; 0.01, <sup>**</sup>
<italic>P</italic> &lt; 0.001, <sup>***</sup>
<italic>P</italic> &lt; 0.0001 or <sup>****</sup>
<italic>P</italic> &lt; 0.00001 in relation to medium (for uninfected cells) or to medium Tg (for infected cells). <sup>&amp;</sup>
<italic>P</italic> &lt; 0.05 in relation to SDZ + PYR (for uninfected or infected cells). <sup>#</sup>
<italic>P</italic> &lt; 0.05 between medium and medium Tg.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113896-g007.tif"/>
</fig>
<p>Regarding IL-8, uninfected BeWo cells reduced or increased the level of this cytokine when treated with SDZ + PYR or 32 &#xb5;g/mL, respectively (<sup>***</sup>
<italic>P</italic> &lt; 0.0001) in relation to untreated cells (medium) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>). Interestingly, 32 &#xb5;g/mL oleoresin triggered a higher release of IL-8 in comparison to SDZ + PYR-treated cells (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>). However, all concentrations of the hydroalcoholic extract and oleoresin downmodulated IL-8 in infected BeWo cells in comparison to untreated/infected cells (medium Tg) (<sup>****</sup>
<italic>P</italic> &lt; 0.00001) or SDZ + PYR-treated cells (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>).</p>
<p>For MIF production, uninfected BeWo cells augmented the release of this cytokine in all concentrations of the hydroalcoholic extract and oleoresin when compared to untreated cells (medium) (<sup>*</sup>
<italic>P</italic> &lt; 0.01, <sup>**</sup>
<italic>P</italic> &lt; 0.001, <sup>****</sup>
<italic>P</italic> &lt; 0.00001) or SDZ + PYR-treated cells (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7E</bold>
</xref>). However, in the presence of infection, untreated and 32 &#xb5;g/mL oleoresin-treated cells upregulated or downmodulated MIF in comparison to medium (<sup>#</sup>
<italic>P</italic> &lt; 0.05) or medium Tg (<sup>***</sup>
<italic>P</italic> &lt; 0.0001), respectively (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7F</bold>
</xref>).</p>
<p>Finally, we measured ROS in BeWo cells infected or not with <italic>T. gondii</italic> and treated or not with the hydroalcoholic extract or oleoresin. We just observed that uninfected cells treated with 32 &#xb5;g/mL of the hydroalcoholic extract augmented the level of ROS in relation to untreated cells (medium) (<sup>*</sup>
<italic>P</italic> &lt; 0.01) and SDZ + PYR-treated cells (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7G</bold>
</xref>). Additionally, infected BeWo cells did not change ROS release in presence of any treatment (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7H</bold>
</xref>).</p>
<p>TNF and IL-10 were not detected in BeWo cell supernatants under any experimental conditions (data not shown).</p>
</sec>
<sec id="s3_6">
<title>Leaf hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> slightly modulated cytokine and ROS production in HTR8/SVneo cells</title>
<p>We also verified cytokine and ROS production in HTR8/SVneo cells infected or not with <italic>T. gondii</italic> and treated with the hydroalcoholic extract or oleoresin.</p>
<p>In the absence of infection, HTR8/SVneo cells increased IL-6 release when treated with the hydroalcoholic extract (8 &#xb5;g/mL) or oleoresin (16 &#xb5;g/mL) in comparison to untreated cells (medium) (<sup>*</sup>
<italic>P</italic> &lt; 0.01, <sup>**</sup>
<italic>P</italic> &lt; 0.001) and SDZ + PYR-treated cells (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). In the presence of infection, untreated HTR8/SVneo cells, as well as cells treated with the hydroalcoholic extract or oleoresin, increased the levels of IL-6 in relation to the medium or SDZ + PYR-treated cells, respectively (<sup>#</sup>
<italic>P</italic> &lt; 0.05, <sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>). Also, IL-6 was lower in SDZ + PYR-treated cells in comparison to untreated and infected cells (medium Tg) (<sup>**</sup>
<italic>P</italic> &lt; 0.001) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Cytokine and ROS production in HTR8/SVneo cells. HTR8/SVneo cells were infected and treated or not with the hydroalcoholic extract or oleoresin from <italic>C. multijuga</italic> for 24&#xa0;h. Untreated and uninfected cells (medium), untreated and infected cells (medium Tg) and SDZ + PYR were used as controls. Then, supernatants were collected and used to measure IL-6 <bold>(A, B)</bold>, IL-8 <bold>(C, D)</bold> and MIF <bold>(E, F)</bold>. In parallel, HTR8/SVneo cells were infected, treated or not with the hydroalcoholic extract or oleoresin from <italic>C. multijuga</italic> for 24&#xa0;h, incubated with the probe 2&#x2032;,7&#x2032;-dichlorodihydrofluorescein diacetate (H2DCF-DA), ROS production was measured by a plate reader and data were expressed as mean fluorescence intensity (MFI) <bold>(G, H)</bold>. The results were expressed as means &#xb1; standard deviation of three experiments performed in eight replicates. Significant differences detected by One-Way ANOVA, Bonferroni&#x2019;s multiple comparisons post-test. <sup>*</sup>
<italic>P</italic> &lt; 0.01, <sup>**</sup>
<italic>P</italic> &lt; 0.001, <sup>***</sup>
<italic>P</italic> &lt; 0.0001 or <sup>****</sup>
<italic>P</italic> &lt; 0.00001 in relation to the medium (for uninfected cells) or to the medium Tg (for infected cells). <sup>&amp;</sup>
<italic>P</italic> &lt; 0.05 in relation to SDZ + PYR (for uninfected or infected cells). <sup>#</sup>
<italic>P</italic> &lt; 0.05 between medium and medium Tg.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113896-g008.tif"/>
</fig>
<p>Regarding IL-8 for uninfected cells, SDZ + PYR reduced IL-8 (<sup>***</sup>
<italic>P</italic> &lt; 0.0001) and all concentrations of the hydroalcoholic extract and oleoresin (<sup>*</sup>
<italic>P</italic> &lt; 0.01, <sup>****</sup>
<italic>P</italic> &lt; 0.00001) increased IL-8 when compared to the medium (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8C</bold>
</xref>). Also, the hydroalcoholic extract and oleoresin presented higher levels of IL-8 in comparison to SDZ + PYR (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8C</bold>
</xref>). When HTR8/SVneo cells were infected by <italic>T. gondii</italic>, IL-8 was augmented in relation to the medium (<sup>#</sup>
<italic>P</italic> &lt; 0.05), SDZ + PYR decreased IL-8 in comparison to only infected cells (medium Tg) (<sup>****</sup>
<italic>P</italic> &lt; 0.00001), and all treatments with the hydroalcoholic extract or oleoresin upregulated IL-8 in relation to SDZ + PYR (<sup>&amp;</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8D</bold>
</xref>).</p>
<p>The MIF production was not significantly changed in uninfected HTR8/SVneo cells, except for uninfected and SDZ + PYR-treated cells (<sup>*</sup>
<italic>P</italic> &lt; 0.01) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8E</bold>
</xref>). Although not statistically different, the hydroalcoholic extract and oleoresin showed an increase in MIF release in infected HTR8/SVneo cells, while only infected cells augmented MIF in comparison to untreated and uninfected cells (<sup>#</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8F</bold>
</xref>).</p>
<p>Finally, we measured ROS in HTR8/SVneo cells infected or not with <italic>T. gondii</italic> and treated or not with the hydroalcoholic extract or oleoresin. We observed that uninfected cells treated with the hydroalcoholic extract, oleoresin or SDZ + PYR presented low levels of ROS in relation to untreated cells (medium) (<sup>*</sup>
<italic>P</italic> &lt; 0.01, <sup>**</sup>
<italic>P</italic> &lt; 0.001, <sup>***</sup>
<italic>P</italic> &lt; 0.0001, <sup>****</sup>
<italic>P</italic> &lt; 0.00001) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8G</bold>
</xref>). Although not statistically different, the hydroalcoholic extract and oleoresin showed a reduction in ROS release in infected HTR8/SVneo cells, while only infected cells diminished ROS in comparison to untreated and uninfected cells (<sup>#</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8H</bold>
</xref>).</p>
<p>TNF and IL-10 were not detected in supernatants under any experimental conditions (data not shown).</p>
</sec>
<sec id="s3_7">
<title>Human chorionic villous explants treated with the hydroalcoholic extract or oleoresin did not alter viability</title>
<p>First, to determine non-toxic concentration to use in the experiments, the villous explant viability after treatments with oleoresin or hydroalcoholic extract was performed by measuring LDH release and MTT assay. Our data showed that both oleoresin and hydroalcoholic extract did not alter tissue viability at any of the concentrations tested when compared to untreated explants (medium). Also, treatment with SDZ + PYR did not cause significant cytotoxicity in villous explants in relation to the untreated group (<xref ref-type="fig" rid="f9">
<bold>Figures&#xa0;9A, B</bold>
</xref>). In addition, treatments did not alter the tissue morphological structure, which was highlighted by the typical morphology of syncytiotrophoblast cells (black arrows) and mesenchyme (*) compared to untreated villous explants (<xref ref-type="fig" rid="f9">
<bold>Figures&#xa0;9C-F</bold>
</xref>).</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>Viability of human villous explants. The villous explants were treated for 24&#xa0;h with hydroalcoholic extract or oleoresin from <italic>C</italic>. <italic>multijuga</italic>, SDZ+PYR or culture medium alone (medium). <bold>(A)</bold> Tissue viability is shown in percentages (% viability by incorporation of MTT). <bold>(B)</bold> Supernatants were collected and used to measure LDH levels (U/L). Representative images of villi incubated with <bold>(C)</bold> culture medium alone, <bold>(D)</bold> SDZ+PYR, 256 &#xb5;g/mL hydroalcoholic extract <bold>(E)</bold>, 256 &#xb5;g/mL oleoresin <bold>(F)</bold>. Data are expressed as means &#xb1; standard deviation of two experiments performed in six replicates. Significant differences detected by One-way ANOVA, Bonferroni&#x2019;s multiple comparisons post-test (statistically significant when <italic>P</italic> &lt; 0.05). Hematoxylin-eosin (HE) stained histological sections show syncytiotrophoblast cells (black arrows) and mesenchyme (*). Scale bar: 50 &#xb5;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113896-g009.tif"/>
</fig>
</sec>
<sec id="s3_8">
<title>The hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> reduced parasite intracellular proliferation, but did not alter the cytokine profile in human chorionic villous explants</title>
<p>We evaluated the effects of the hydroalcoholic extract and oleoresin (256 and 128 &#xb5;g/mL) on the control of <italic>T. gondii</italic> intracellular proliferation in human chorionic villi using the &#x3b2;-galactosidase assay. We observed that treatments at both concentrations significantly reduced the percentage of intracellular parasites in comparison to untreated/infected explants (considered as 100% proliferation) (<sup>****</sup>
<italic>P</italic> &lt; 0.00001). As expected, treatment with SDZ + PYR also inhibited parasite growth (<sup>****</sup>
<italic>P</italic> &lt; 0.00001) when compared to the untreated group (medium) (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10</bold>
</xref>).</p>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>
<italic>T. gondii</italic> intracellular proliferation. The human villous explants were infected with <italic>T. gondii</italic> followed by treatment for an additional 24&#xa0;h with hydroalcoholic extract, oleoresin, SDZ+PYR or culture medium alone (medium). <italic>T. gondii</italic> intracellular proliferation was measured by &#x3b2;-galactosidase assay, and the number of tachyzoites was expressed as a percentage (% of <italic>T. gondii</italic> proliferation), and the untreated/infected (medium) was considered as 100% parasite proliferation. Data are expressed as means &#xb1; standard deviation of four experiments performed in six replicates. <sup>*</sup>Comparison with infected/untreated cells (<sup>****</sup>
<italic>P</italic> &lt; 0.00001). Significant differences detected by One-way ANOVA, Bonferroni&#x2019;s multiple comparisons post-test differences were considered when <italic>P</italic> &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113896-g010.tif"/>
</fig>
<p>In addition, we evaluated whether the hydroalcoholic extract and oleoresin would modulate the cytokine profile in chorionic villi. Our results showed that IL-6, IL-8, MIF and TNF showed no significant change in their production when uninfected explants were treated with both hydroalcoholic extract or oleoresin if compared to medium, except for TNF when 256 &#xb5;g/mL hydroalcoholic extract was added in the samples (<sup>*</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). Finally, <italic>T. gondii</italic> infection reduced the levels of all cytokines in comparison to untreated explants (medium), regardless of hydroalcoholic extract and oleoresin treatments (<sup>#</sup>
<italic>P</italic> &lt; 0.05) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Toxoplasmosis is considered as a global health problem with nearly a billion people infected, reaching a prevalence of the disease in 71.5% (<xref ref-type="bibr" rid="B3">Ahmadpour et&#xa0;al., 2019</xref>). Regarding the treatment, a combination of sulfadiazine and pyrimethamine (SDZ + PYR) is the first choice to treat congenital toxoplasmosis, one of the most serious forms of the disease (<xref ref-type="bibr" rid="B1">Abugri et&#xa0;al., 2019</xref>). Despite the great clinical importance, the conventional treatment for congenital toxoplasmosis is currently limited, and it is also linked to serious side effects in both the mother and the child (<xref ref-type="bibr" rid="B39">Montoya and Remington, 2008</xref>; <xref ref-type="bibr" rid="B29">Halonen and Weiss, 2013</xref>). In this sense, the search for alternative therapeutic tools has gained attention.</p>
<p>In order to assess the impact of both the leaf hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> in the <italic>T. gondii</italic> infection, we used BeWo and HTR8/SVneo cells as villous and extravillous trophoblast cell models, respectively, being considered as excellent experimental models for the study of congenital toxoplasmosis <italic>in vitro</italic> (<xref ref-type="bibr" rid="B7">Barbosa et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B59">Souza et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B62">Teixeira et&#xa0;al., 2021</xref>). Firstly, the viability assay was performed. Next, the parasite replication revealed that both compounds efficiently inhibited the <italic>T. gondii</italic> intracellular proliferation and triggered an irreversible effect on tachyzoites.</p>
<p>In agreement with our data, studies have already demonstrated that oleoresins from <italic>Copaifera</italic> present activity against some pathogens. <italic>C. pubiflora</italic> and its compound (<italic>ent</italic>-hardwickiic acid) showed antibacterial properties and should be explored as new therapeutic alternatives to treat oral diseases such as dental caries and endodontic infections (<xref ref-type="bibr" rid="B40">Moraes et&#xa0;al., 2020</xref>). <xref ref-type="bibr" rid="B47">Pieri (2012)</xref> determined that copalic acid and &#x3b2;-caryophyllene are common components obtained from oleoresins and suggested that the bioactivity of the <italic>Copaifera</italic> oleoresin on <italic>Trypanosoma cruzi</italic> replication is due to this synergism. Additionally, terpenes isolated from <italic>Copaifera</italic> oleoresins promoted changes in oxidative metabolism, induced autophagy and decreased the replicative forms of <italic>T. cruzi</italic>, in particular amastigotes (<xref ref-type="bibr" rid="B32">Izumi et&#xa0;al., 2012</xref>). <xref ref-type="bibr" rid="B31">Izumi et&#xa0;al. (2013)</xref> tested oleoresins of eight species of <italic>Copaifera</italic> against <italic>T. cruzi</italic>, and oleoresin from <italic>C. martii</italic> and <italic>C. officinalis</italic> exhibited the best activity against replicative forms of the parasite. A more recent study demonstrated that oleoresin and kaurenoic acid from <italic>C. martii</italic> decreased <italic>T. cruzi</italic> amastigote proliferation in murine peritoneal macrophages and HeLa cells (<xref ref-type="bibr" rid="B33">Kian et&#xa0;al., 2018</xref>). In addition, murine peritoneal macrophages treated with <italic>C. reticulata</italic> oil controlled significantly the infection by <italic>Leishmania amazonensis</italic> (<xref ref-type="bibr" rid="B53">Santos et&#xa0;al., 2008</xref>), while <italic>C. martii</italic> oil promoted a reduction on the size lesion caused by <italic>L. amazonensis</italic> in BALB/c (<xref ref-type="bibr" rid="B52">Santos et&#xa0;al., 2011</xref>). Similarly, the treatment with nanoemulsion from <italic>Copaifera</italic> led to a reduction in <italic>L. infantum</italic> and <italic>L. amazonensis</italic> infection levels in macrophage cultures, as well as presented beneficial effects on the lesion size and parasite burden in BALB/c (<xref ref-type="bibr" rid="B19">De Moraes et&#xa0;al., 2018</xref>). Also, human fibroblast treated with oleoresin from <italic>C. reticulata</italic> showed activity against the <italic>Plasmodium falciparum</italic> W2 and 3D7 strains and reduced the parasitemia in BALB/c (<xref ref-type="bibr" rid="B57">Souza et&#xa0;al., 2017</xref>). Finally, our previous study showed that oleoresins from <italic>C. reticulata</italic>, <italic>C. duckei</italic>, <italic>C. paupera</italic> and <italic>C. pubiflora</italic> induced a significant reduction on <italic>T. gondii</italic> infection in BeWo cells (<xref ref-type="bibr" rid="B61">Teixeira et&#xa0;al., 2020</xref>). Until the present moment, no study was conducted to verify the effects of hydroalcoholic extracts from <italic>Copaifera</italic> against <italic>T. gondii</italic>, systemically or in maternal-fetal interface; and also there is no study about the effect of the hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> on <italic>T. gondii</italic> infection. Thus, the present study is the first to show these effects.</p>
<p>It is important to emphasize that HTR8/SVneo cells are experimental model of human extravillous trophoblast cells (<xref ref-type="bibr" rid="B59">Souza et&#xa0;al., 2021</xref>). This type of trophoblast is important to invade the myometrium in order to interpose between the endothelial cells and guarantee the adequate blood supply to the embryo (<xref ref-type="bibr" rid="B4">Aplin et&#xa0;al., 2020</xref>). Our previous study demonstrated that extravillous trophoblasts are more susceptible to <italic>T. gondii</italic> infection in comparison to villous trophoblast (<xref ref-type="bibr" rid="B42">Oliveira et&#xa0;al., 2021</xref>). Thus, it is possible to conclude that extravillous trophoblast cells are a potential entry for tachyzoites gain the embryonic and placental tissues, maybe the major transmission route. In the present study, we verified that oleoresin and hydroalcoholic extract from <italic>C. multijuga</italic> reduced significantly the infection in HTR8/SVneo cells. It means that these compounds are great tools to control the vertical transmission of <italic>T. gondii</italic> when it occurs by the extravillous trophoblast route. One more time, the present study is the first to show these effects.</p>
<p>
<italic>T. gondii</italic> is an obligate intracellular protozoan parasite capable of infecting a wide variety of nucleated cells (<xref ref-type="bibr" rid="B22">Dubey and Jones, 2008</xref>). Therefore, the successful establishment of the infection requires the ability of the parasite to adhere, invade and proliferate within the host cell (<xref ref-type="bibr" rid="B28">Hall et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B2">Adeyemi et&#xa0;al., 2017</xref>). Therefore, the next question that we would like to determine was the direct action of the hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> on tachyzoites. Pretreated parasite demonstrated a lower capacity to adhere, invade and proliferate in both cells. These findings are in agreement with our previous study, in which preincubated tachyzoites with oleoresins from <italic>C. reticulata</italic>, <italic>C. duckei</italic>, <italic>C. paupera</italic> and <italic>C. pubiflora</italic> showed lower rates of adhesion, invasion and proliferation in BeWo cells (<xref ref-type="bibr" rid="B61">Teixeira et&#xa0;al., 2020</xref>). However, other studies have already demonstrated that parasites pretreated with other drugs also showed reduced ability to infection. <xref ref-type="bibr" rid="B17">Castro-Filice et&#xa0;al. (2014)</xref> showed that the pretreatment of <italic>T. gondii</italic> with a combination of SDZ + PYR + folinic acid or azithromycin reduced the parasite proliferation after 72&#xa0;h in human villous explants. Similarly, tachyzoites from atypical strains of <italic>T. gondii</italic> pretreated with azithromycin or spiramycin had a lower capacity to invade and replicate in BeWo cells (<xref ref-type="bibr" rid="B50">Ribeiro et&#xa0;al., 2017</xref>). Thus, the pretreatment with oleoresin and hydroalcoholic extract from <italic>C. multijuga</italic> suggested that these compounds can directly affect the parasite structure and, consequently, decrease its functional capabilities. A recent study declared that these natural compounds can affect different structures in <italic>T. cruzi</italic> and <italic>Leishmania</italic> spp, and it is hypothesized that the mitochondrion is a strategic target to induce parasite death (<xref ref-type="bibr" rid="B35">Lazarin-Bid&#xf3;ia et&#xa0;al., 2022</xref>). Also, <italic>L. infantum</italic> and <italic>L. amazonensis</italic> promastigotes treated with nanoemulsion from <italic>Copaifera</italic> presented ultrastructural alterations as oval cell shape and retracted flagella (<xref ref-type="bibr" rid="B19">De Moraes et&#xa0;al., 2018</xref>). Our previous study demonstrated that <italic>C. paupera, C. reticulata, C. pubiflora</italic> and <italic>C. duckei</italic> induced tethered <italic>T. gondii</italic> tachyzoites, which dampen the cytokinesis (<xref ref-type="bibr" rid="B61">Teixeira et&#xa0;al., 2020</xref>). Future studies are necessary to investigate the types of structural changes that occur in <italic>T. gondii</italic> when treated with these compounds from <italic>C. multijuga.</italic>
</p>
<p>In a second moment, after demonstrating the effect of <italic>C. multijuga</italic> on tachyzoites replication, as well as adhesion and invasion, we investigated the immune response of host cells, suggesting that these compounds could be involved in the modulation of the host&#x2019;s cellular environment.</p>
<p>It was observed that BeWo cells upregulated IL-6 and downmodulated IL-8. It is widely known that IL-6 is an important cytokine involved in <italic>T. gondii</italic> control in various cell types, such as macrophages and monocytes (<xref ref-type="bibr" rid="B45">Pereira et&#xa0;al., 2019</xref>) and human and murine trophoblasts (<xref ref-type="bibr" rid="B7">Barbosa et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B6">Barbosa et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B26">Gomes et&#xa0;al., 2018</xref>). Thus, it is plausible to suggest that the higher IL-6 in BeWo cells infected and treated with hydroalcoholic extract or oleoresin was important to control <italic>T. gondii</italic> replication. Although MIF is a cytokine important during <italic>T. gondii</italic> infection (<xref ref-type="bibr" rid="B55">Silva et&#xa0;al., 2017</xref>), the level of this cytokine increased only in uninfected treated-BeWo cells or oleoresin treated-cell at 32 &#xb5;g/mL, then it seems that MIF did not contribute to parasite control when oleoresin or hydroalcoholic extract are used in BeWo cells. IL-8 has emerged as a cytokine important to disseminate <italic>T. gondii</italic> infection (<xref ref-type="bibr" rid="B56">Sommerville et&#xa0;al., 2013</xref>). Our previous study showed low levels of IL-8 in THP-1 cells infected by <italic>T. gondii</italic> and inhibited for cyclooxygenase 2 (COX-2), which contributes to the control of parasite replication (<xref ref-type="bibr" rid="B45">Pereira et&#xa0;al., 2019</xref>). In this sense, it is possible to hypothesize that the low levels of IL-8 in BeWo cells treated with the hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> could have contributed to <italic>T. gondii</italic> control. Future studies are necessary to verify the influence of <italic>Copaifera</italic> on COX-2 modulation. Therefore, in BeWo cells, the <italic>T. gondii</italic> control mediated by the hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> was an association between the direct action of these compounds on tachyzoites, as well as the immune response of these cells. For HTR8/SVneo cells, cytokines were slightly modulated (not statistically significant) when compared to untreated/infected cells. Thus, it is possible to conclude that cytokines did not contribute to <italic>T. gondii</italic> control in HTR8/SVneo cells when treated with compounds from <italic>C. multijuga</italic>. Thus, in this case, the direct action of these compounds on tachyzoites was the only mechanism to downmodulate infection in these cell types. As HTR8/SVneo cells are representative of human extravillous trophoblast (<xref ref-type="bibr" rid="B59">Souza et&#xa0;al., 2021</xref>), a potent route for congenital toxoplasmosis, and both oleoresin and hydroalcoholic extract controlled <italic>T. gondii</italic> infection in these cells without change significantly the cytokine profile, it is possible to conclude that both compounds from <italic>C. multijuga</italic> are an excellent alternative strategy to prevent vertical transmission and maintain the immune profile required for a successful pregnancy. Finally, the ROS production was not significant in infected and treated BeWo and HTR8/SVneo cells.</p>
<p>Finally, we investigated the effect of oleoresin and hydroalcoholic extract in human villous explants from third-trimester pregnancy, and we also observed reduced <italic>T. gondii</italic> intracellular proliferation, even with no change in cytokine profile, suggesting a direct effect of both compounds on tachyzoites. One more time, both compounds from <italic>C. multijuga</italic> showed to be an excellent alternative strategy to prevent vertical transmission and maintain the immune profile required for a successful pregnancy. Cell cultures are notorious examples of <italic>in vitro</italic> studies. However, the placental explants are very important to validate the data obtained with cell lineages, since these cells can be very different from the natural environment. Then, in studies of maternal-fetal interface, the association between <italic>in vitro</italic> (cells) and <italic>ex vivo</italic> (explants) studies (<xref ref-type="bibr" rid="B51">Rosini et&#xa0;al., 2022</xref>) is mandatory, and we demonstrated that both oleoresin and hydroalcoholic extract are enough to control <italic>T. gondii</italic> infection in both trophoblast cells and villous explants.</p>
<p>Based on the results of the study, the leaf hydroalcoholic extract and oleoresin obtained from <italic>C. multijuga</italic> presented different antiparasitic activities in a dependent manner of the experimental model. For BeWo, representative of human villous trophoblast, <italic>C. multijuga</italic> presented a direct action in tachyzoite and modulated the immune response, whereas only the direct effect in tachyzoites participated of the parasite control in HTR8/SVneo cells, representative of human extravillous trophoblast, and human explants. Considering all these parameters, the leaf hydroalcoholic extract and oleoresin from <italic>C. multijuga</italic> can be a target for the establishment of new therapeutic strategies for congenital toxoplasmosis. However, more detailed studies are needed to evaluate the bioactive components and other possible mechanisms of these compounds.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by Ethics Committee of the Federal University of Uberlandia, MG, Brazil. Approval number 3.679.426. Written informed consent to participate in this study was provided by the participants&#x2019; legal guardian/next of kin.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>ST and BB design the experiments. AM, ST, GS, AR. JJ, GM, and&#xa0;BB performed the experiments. ST, KB, AM, and BB analyzed the data. SA, RV, JB, and CM were responsible for the identification and collection of <italic>Copaifaera</italic> spp. oleoresin and hydroalcoholic extract. BB, ST, AG, CM, and EF, participated in the data interpretation. AM and BB discussed the findings. ST, GS, and BB, reviewed the manuscript. All authors approved the final version of the manuscript.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by Brazilian Researcher Agencies: Conselho Nacional de Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico (CNPq), Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de Minas Gerais (FAPEMIG, APQ-01629-22), and Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo (FAPESP, # 2017/02858-3). This study was financed in part by the Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de N&#xed;vel Superior &#x2013; Brazil (CAPES) &#x2013; Finance Code 001.</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2023.1113896/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2023.1113896/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.tif" id="SM1" mimetype="image/tiff">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>Cytokine production in villous explants. Explants were infected and treated or not with the hydroalcoholic extract or oleoresin from <italic>C. multijuga</italic> for 24&#xa0;h. Untreated and uninfected explants (medium), untreated and infected explants (medium Tg) and SDZ + PYR were used as controls. Then, supernatants were collected and used to measure IL-6 <bold>(A, B)</bold>, IL-8 <bold>(C, D)</bold>, MIF <bold>(E, F)</bold> and TNF <bold>(G, H)</bold>. The results were expressed as means &#xb1; standard deviation of four experiments performed in six replicates. Significant differences detected by One-Way ANOVA, Bonferroni&#x2019;s multiple comparisons post-test. <sup>*</sup>
<italic>P</italic> &lt; 0.05 in relation to medium (for uninfected cells). <sup>#</sup>
<italic>P</italic> &lt; 0.05 between medium and medium Tg.</p>
</caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abugri</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Jaynes</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Witola</surname> <given-names>W. H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Anti-<italic>Toxoplasma</italic> activity of sorghum bicolor-derived lipophilic fractions</article-title>. <source>BMC Res. Notes</source> <volume>12</volume> (<issue>1</issue>), <fpage>688</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13104-019-4732-z</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adeyemi</surname> <given-names>O. S.</given-names>
</name>
<name>
<surname>Murata</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Sugi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kato</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Inorganic nanoparticles kill <italic>Toxoplasma gondii via</italic> changes in redox status and mitochondrial membrane potential</article-title>. <source>Int. J. Nanomed.</source> <volume>12</volume>, <fpage>1647</fpage>&#x2013;<lpage>1661</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/IJN.S122178</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmadpour</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Zargami</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Mahami-Oskouei</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Spotin</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Shahbazi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kafil</surname> <given-names>H. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Diagnosis of <italic>Toxoplasma gondii</italic> infection in pregnant women using automated chemiluminescence and quantitative real time PCR</article-title>. <source>Asian Pac. J. Trop. Med.</source> <volume>12</volume> (<issue>1</issue>), <fpage>26</fpage>&#x2013;<lpage>31</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/1995-7645.250341</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aplin</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Myers</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Timms</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Westwood</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Tracking placental development in health and disease</article-title>. <source>Nat. Rev. Endocrinol.</source> <volume>16</volume>, <fpage>479</fpage>&#x2013;<lpage>494</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41574-020-0372-6</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arruda</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Mej&#xed;a</surname> <given-names>J. A. A.</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>V. P.</given-names>
</name>
<name>
<surname>Borges</surname> <given-names>C. H. G.</given-names>
</name>
<name>
<surname>Martins</surname> <given-names>C. H. G.</given-names>
</name>
<name>
<surname>Veneziani</surname> <given-names>R. C. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Occurrence, chemical composition, biological activities and analytical methods on <italic>Copaifera</italic> genus - a review</article-title>. <source>Biomed. Pharmacother.</source> <volume>109</volume>, <fpage>1</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2018.10.030</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbosa</surname> <given-names>B. F.</given-names>
</name>
<name>
<surname>Lopes-Maria</surname> <given-names>J. B.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Angeloni</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Franco</surname> <given-names>P. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>IL10, TGF Beta1, and IFN gamma modulate intracellular signaling pathways and cytokine production to control <italic>Toxoplasma gondii</italic> infection in BeWo trophoblast cells</article-title>. <source>Biol. Reprod.</source> <volume>92</volume> (<issue>3</issue>), <fpage>82</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1095/biolreprod.114.124115</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbosa</surname> <given-names>B. F.</given-names>
</name>
<name>
<surname>Paulesu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Ietta</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Bechi</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Romagnoli</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>A. O.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Susceptibility to <italic>Toxoplasma gondii</italic> proliferation in BeWo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), <italic>via</italic> ERK1/2 phosphorylation and prostaglandin E2 production</article-title>. <source>Placenta</source> <volume>35</volume> (<issue>3</issue>), <fpage>152</fpage>&#x2013;<lpage>162</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.placenta.2013.12.013</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blader</surname> <given-names>I. J.</given-names>
</name>
<name>
<surname>Coleman</surname> <given-names>B. I.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C. T.</given-names>
</name>
<name>
<surname>Gubbels</surname> <given-names>M. J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Lytic cycle of <italic>Toxoplasma gondii</italic> 15 years later</article-title>. <source>Annu. Rev. Microbiol.</source> <volume>69</volume>, <fpage>463</fpage>&#x2013;<lpage>485</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-micro-091014-104100</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borges</surname> <given-names>I. P.</given-names>
</name>
<name>
<surname>Castanheira</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Barbosa</surname> <given-names>B. F.</given-names>
</name>
<name>
<surname>de Souza</surname> <given-names>D. L. N.</given-names>
</name>
<name>
<surname>da Silva</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Mineo</surname> <given-names>J. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Anti-parasitic effect on <italic>Toxoplasma gondii i</italic>nduced by BnSP-7, a Lys49-phospholipase A2 homologue from <italic>Bothrops pauloensis</italic> venom</article-title>. <source>Toxicon</source> <volume>119</volume>, <fpage>84</fpage>&#x2013;<lpage>91</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.toxicon.2016.05.010</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradford</surname> <given-names>M. M.</given-names>
</name>
</person-group> (<year>1976</year>). <article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title>. <source>Anal. Biochem.</source> <volume>72</volume>, <fpage>248</fpage>&#x2013;<lpage>254</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/abio.1976.9999</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buzoni-Gatel</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Schulthess</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Menard</surname> <given-names>L. C.</given-names>
</name>
<name>
<surname>Kasper</surname> <given-names>L. H.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Mucosal defences against orally acquired protozoan parasites, emphasis on <italic>Toxoplasma gondii</italic> infections</article-title>. <source>Cell. Microbiol.</source> <volume>8</volume> (<issue>4</issue>), <fpage>535</fpage>&#x2013;<lpage>544</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1462-5822.2006.00692.x</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlier</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Truyens</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Deloron</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Peyron</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Congenital parasitic infections: A review</article-title>. <source>Acta Trop.</source> <volume>121</volume> (<issue>2</issue>), <fpage>55</fpage>&#x2013;<lpage>70</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.actatropica.2011.10.018</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carruthers</surname> <given-names>V. B.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Host cell invasion by the opportunistic pathogen</article-title>. <source>Toxoplasma gondii. Acta Trop.</source> <volume>1</volume> (<issue>2</issue>), <fpage>111</fpage>&#x2013;<lpage>122</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0001-706X(01)00201-7</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cascon</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Characterization of the chemical composition of oleoresins of <italic>Copaifera guianensis</italic> desf., <italic>Copaifera duckei</italic> dwyer and <italic>Copaifera multijuga</italic> hayne</article-title>. <source>Phytochemistry</source> <volume>55</volume> (<issue>7</issue>), <fpage>773</fpage>&#x2013;<lpage>778</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0031-9422(00)00284-3</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castanheira</surname> <given-names>L.</given-names>
</name>
<name>
<surname>de Souza</surname> <given-names>D. L. N.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Barbosa</surname> <given-names>B. F.</given-names>
</name>
<name>
<surname>Mineo</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Tudini</surname> <given-names>K. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Insights into anti-parasitism induced by a c-type lectin from <italic>Bothrops pauloensis</italic> venom on toxoplasma gondii</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>74</volume>, <fpage>568</fpage>&#x2013;<lpage>574</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijbiomac.2014.11.035</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castro</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Alves</surname> <given-names>C. M. O. S.</given-names>
</name>
<name>
<surname>Angeloni</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Barbosa</surname> <given-names>B. F.</given-names>
</name>
<name>
<surname>Franco</surname> <given-names>P. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Trophoblast cells are able to regulate monocyte activity to control <italic>Toxoplasma gondii</italic> infection</article-title>. <source>Placenta</source> <volume>34</volume> (<issue>3</issue>), <fpage>240</fpage>&#x2013;<lpage>247</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.placenta.2012.12.006</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castro-Filice</surname> <given-names>L. S.</given-names>
</name>
<name>
<surname>Barbosa</surname> <given-names>B. F.</given-names>
</name>
<name>
<surname>Angeloni</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>N. M.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Alves</surname> <given-names>C. M. O. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Azithromycin is able to control <italic>Toxoplasma gondii</italic> infection in human villous explants</article-title>. <source>J. Transl. Med.</source> <volume>12</volume>, <elocation-id>132</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1479-5876-12-132</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname> <given-names>I. N.</given-names>
</name>
<name>
<surname>Angeloni</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Santana</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Barbosa</surname> <given-names>B. F.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>M. C. P.</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>A. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Azithromycin inhibits vertical transmission of <italic>Toxoplasma gondii</italic> in <italic>Calomys callosus</italic> (Rodentia: Cricetidae)</article-title>. <source>Placenta</source> <volume>30</volume> (<issue>10</issue>), <fpage>884</fpage>&#x2013;<lpage>890</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.placenta.2009.08.002</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Moraes</surname> <given-names>A. R. D. P.</given-names>
</name>
<name>
<surname>Tavares</surname> <given-names>G. D.</given-names>
</name>
<name>
<surname>Rocha</surname> <given-names>F. J. S.</given-names>
</name>
<name>
<surname>de Paula</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Giorgio</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Effects of nanoemulsions prepared with essential oils of copaiba- and andiroba against <italic>Leishmania infantum</italic> and <italic>Leishmania amazonensis</italic> infections</article-title>. <source>Exp. Parasitol.</source> <volume>187</volume>, <fpage>12</fpage>&#x2013;<lpage>21</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.exppara.2018.03.005</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doliwa</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Escotte-Binet</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Aubert</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Sauvage</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Velard</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Schmid</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Sulfadiazine resistance in <italic>Toxoplasma gondii</italic> : no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters</article-title>. <source>Parasite</source> <volume>20</volume>, <fpage>19</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1051/parasite/2013020</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Interleukin-8: A critical chemokine in biliary atresia</article-title>. <source>J. Gastroenterol. Hepatol.</source> <volume>30</volume> (<issue>6</issue>), <fpage>970</fpage>&#x2013;<lpage>976</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jgh.12900</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubey</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>
<italic>Toxoplasma gondii</italic> infection in humans and animals in the united states</article-title>. <source>Int. J. Parasitol.</source> <volume>38</volume> (<issue>11</issue>), <fpage>1257</fpage>&#x2013;<lpage>1278</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijpara.2008.03.007</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elsheikha</surname> <given-names>H. M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Congenital toxoplasmosis: Priorities for further health promotion action</article-title>. <source>Public Health</source> <volume>122</volume> (<issue>4</issue>), <fpage>335</fpage>&#x2013;<lpage>353</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.puhe.2007.08.009</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fitch</surname> <given-names>W.</given-names>
</name>
<name>
<surname>MacKenzie</surname> <given-names>E. T.</given-names>
</name>
<name>
<surname>Harper</surname> <given-names>A. M.</given-names>
</name>
</person-group> (<year>1975</year>). <article-title>Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. influence of the sympathetic nervous system</article-title>. <source>Circ. Res.</source> <volume>37</volume> (<issue>5</issue>), <fpage>550</fpage>&#x2013;<lpage>557</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/01.res.37.5.550</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fowler</surname> <given-names>N. O.</given-names>
</name>
<name>
<surname>McCall</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Chou</surname> <given-names>T. C.</given-names>
</name>
<name>
<surname>Holmes</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Hanenson</surname> <given-names>I. B.</given-names>
</name>
</person-group> (<year>1976</year>). <article-title>Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs</article-title>. <source>Am. J. Cardiol.</source> <volume>37</volume> (<issue>2</issue>), <fpage>223</fpage>&#x2013;<lpage>230</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0002-9149(76)90316-7</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomes</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Barbosa</surname> <given-names>B. F.</given-names>
</name>
<name>
<surname>Franco</surname> <given-names>P. S.</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Gois</surname> <given-names>P. S. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Macrophage migration inhibitory factor (MIF) prevents maternal death, but contributes to poor fetal outcome during congenital toxoplasmosis</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2018.00906</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Habib</surname> <given-names>F. A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Post-treatment assessment of acute <italic>Toxoplasma</italic> infection during pregnancy</article-title>. <source>J. Obstet. Gynaecol.</source> <volume>28</volume> (<issue>6</issue>), <fpage>593</fpage>&#x2013;<lpage>595</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/01443610802344332</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname> <given-names>C. I.</given-names>
</name>
<name>
<surname>Reese</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Weerapana</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Child</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Bowyer</surname> <given-names>P. W.</given-names>
</name>
<name>
<surname>Albrow</surname> <given-names>V. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Chemical genetic screen identifies <italic>Toxoplasma</italic> DJ-1 as a regulator of parasite secretion, attachment, and invasion</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>108</volume> (<issue>26</issue>), <fpage>10568</fpage>&#x2013;<lpage>10573</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1105622108</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halonen</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Weiss</surname> <given-names>L. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Toxoplasmosis</article-title>. <source>Handb. Clin. Neurol.</source> <volume>114</volume>, <fpage>125</fpage>&#x2013;<lpage>145</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/B978-0-444-53490-3.00008-X</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>N.</given-names>
</name>
<name>
<surname>He</surname> <given-names>J. K.</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>Z. F.</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>Y. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>
<italic>In vitro</italic> anti-parasitic activity of <italic>Pelargonium x. asperum</italic> essential oil against</article-title>. <source>Toxoplasma gondii. Front. Cell. Dev. Biol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2021.616340</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izumi</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Ueda-Nakamura</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Veiga-J&#xfa;nior</surname> <given-names>V. F.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>C. V.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Toxicity of oleoresins from the genus <italic>Copaifera</italic> in <italic>Trypanosoma cruzi</italic>: A comparative study</article-title>. <source>Planta. Med.</source> <volume>79</volume> (<issue>11</issue>), <fpage>952</fpage>&#x2013;<lpage>958</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/s-0032-1328712</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izumi</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Ueda-Nakamura</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Veiga-J&#xfa;nior</surname> <given-names>V. F.</given-names>
</name>
<name>
<surname>Pinto</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>C. V.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Terpenes from <italic>Copaifera</italic> demonstrated <italic>in vitro</italic> antiparasitic and synergic activity</article-title>. <source>J. Med. Chem.</source> <volume>55</volume> (<issue>7</issue>), <fpage>2994</fpage>&#x2013;<lpage>3001</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/jm201451h</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kian</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Lancheros</surname> <given-names>C. A. C.</given-names>
</name>
<name>
<surname>Assolini</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Arakawa</surname> <given-names>N. S.</given-names>
</name>
<name>
<surname>Veiga-J&#xfa;nior</surname> <given-names>V. F.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>C. V.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Trypanocidal activity of copaiba oil and kaurenoic acid does not depend on macrophage killing machinery</article-title>. <source>Biomed. Pharmacother.</source> <volume>103</volume>, <fpage>1294</fpage>&#x2013;<lpage>1301</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2018.04.164</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kodjikian</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Toxoplasmose et grossesse</article-title>. <source>J. Fran&#xe7;ais d&#x2019;Ophtalmologie</source> <volume>33</volume> (<issue>5</issue>), <fpage>362</fpage>&#x2013;<lpage>367</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jfo.2010.03.002</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazarin-Bid&#xf3;ia</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Garcia</surname> <given-names>F. P.</given-names>
</name>
<name>
<surname>Ueda-Nakamura</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>S. O.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>C. V.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Natural compounds based chemotherapeutic against chagas disease and leishmaniasis: mitochondrion as a strategic target</article-title>. <source>Mem. Inst. Oswaldo Cruz</source> <volume>117</volume>, <elocation-id>e220396</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/0074-02760220396</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Boulter</surname> <given-names>N. R.</given-names>
</name>
<name>
<surname>Ikin</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>N. C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The immunobiology of the innate response to <italic>Toxoplasma gondii</italic>
</article-title>. <source>Int. J. Parasitol.</source> <volume>39</volume> (<issue>1</issue>), <fpage>23</fpage>&#x2013;<lpage>39</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijpara.2008.08.002</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miranda</surname> <given-names>N. C.</given-names>
</name>
<name>
<surname>Araujo</surname> <given-names>E. C. B.</given-names>
</name>
<name>
<surname>Justino</surname> <given-names>A. B.</given-names>
</name>
<name>
<surname>Cariaco</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Mota</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Costa-Nascimento</surname> <given-names>L. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Anti-parasitic activity of <italic>Annona muricata</italic> l. leaf ethanolic extract and its fractions against <italic>Toxoplasma gondii in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>J. Ethnopharmacol.</source> <volume>273</volume>, <elocation-id>114019</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2021.114019</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montoya</surname> <given-names>J. G.</given-names>
</name>
<name>
<surname>Liesenfeld</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Toxoplasmosis</article-title>. <source>Lancet</source> <volume>363</volume> (<issue>9425</issue>), <fpage>1965</fpage>&#x2013;<lpage>1976</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(04)16412-X</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montoya</surname> <given-names>J. G.</given-names>
</name>
<name>
<surname>Remington</surname> <given-names>J. S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Management of <italic>Toxoplasma gondii</italic> infection during pregnancy</article-title>. <source>Clin. Infect. Dis.</source> <volume>47</volume> (<issue>4</issue>), <fpage>554</fpage>&#x2013;<lpage>566</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/590149</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moraes</surname> <given-names>T. S.</given-names>
</name>
<name>
<surname>Leandro</surname> <given-names>L. F.</given-names>
</name>
<name>
<surname>Santiago</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>L. O.</given-names>
</name>
<name>
<surname>Bianchi</surname> <given-names>T. C.</given-names>
</name>
<name>
<surname>Veneziani</surname> <given-names>R. C. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Assessment of the antibacterial, antivirulence, and action mechanism of <italic>Copaifera pubiflora oleoresin</italic> and isolated compounds against oral bacteria</article-title>. <source>Biomed. Pharmacother.</source> <volume>129</volume>, <elocation-id>110467</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2020.110467</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mosmann</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays</article-title>. <source>J. Immunol. Methods</source> <volume>65</volume> (<issue>1-2</issue>), <fpage>55</fpage>&#x2013;<lpage>63</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0022-1759(83)90303-4</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname> <given-names>F. C.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Guirelli</surname> <given-names>P. M.</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>A. O.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>ERK1/2 phosphorylation and IL-6 production are involved in the differential susceptibility to <italic>Toxoplasma gondii</italic> infection in three types of human (cyto/ syncytio/ extravillous) trophoblast cells</article-title>. <source>Tissue Cell</source> <volume>72</volume>, <elocation-id>101544</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tice.2021.101544</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname> <given-names>J. G.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>N. M.</given-names>
</name>
<name>
<surname>Santos</surname> <given-names>A. A. D.</given-names>
</name>
<name>
<surname>Souza</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>G. L. S.</given-names>
</name>
<name>
<surname>Mineo</surname> <given-names>J. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>BeWo trophoblasts are unable to control replication of <italic>Toxoplasma gondii</italic>, even in the presence of exogenous IFN-&#x3b3;</article-title>. <source>Placenta</source> <volume>27</volume> (<issue>6-7</issue>), <fpage>691</fpage>&#x2013;<lpage>698</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.placenta.2005.06.006</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oz</surname> <given-names>H. S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Toxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone</article-title>. <source>Front. Microbiol.</source> <volume>5</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2014.00484</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname> <given-names>A. C. A.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Franco</surname> <given-names>P. S.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Souza</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Milian</surname> <given-names>I. C. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Cyclooxygenase (COX)-2 inhibitors reduce <italic>Toxoplasma gondii</italic> infection and upregulate the pro-inflammatory immune response in <italic>Calomys callosus</italic> rodents and human monocyte cell line</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2019.00225</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peyron</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Mc Leod</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ajzenberg</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Contopoulos-Ioannidis</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Kieffer</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Mandelbrot</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Congenital toxoplasmosis in France and the united states: One parasite, two diverging approaches</article-title>. <source>PloS Negl. Trop. Dis.</source> <volume>11</volume> (<issue>2</issue>), <elocation-id>e0005222</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0005222</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pieri</surname> <given-names>F. A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Synergistic activity between terpenes from <italic>Copaifera</italic> genus against the etiological agent of chagas disease</article-title>. <source>Rev. Virtual Quim.</source> <volume>4</volume> (<issue>3</issue>), <fpage>343</fpage>&#x2013;<lpage>346</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.5935/1984-6835.20120025</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pimenta</surname> <given-names>I. P.</given-names>
</name>
<name>
<surname>Abr&#xe3;o</surname> <given-names>F.</given-names>
</name>
<name>
<surname>da Silva</surname> <given-names>J. J. M.</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>L. C.</given-names>
</name>
<name>
<surname>Rogez</surname> <given-names>H. L. G.</given-names>
</name>
<name>
<surname>Ambr&#xf3;sio</surname> <given-names>S. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Antibacterial profile of copaifera multijuga oleoresin and hydroalcoholic extract of leaves against oral pathogens</article-title>. <source>Curr. Dentistry</source> <volume>1</volume> (<issue>1</issue>), <fpage>53</fpage>&#x2013;<lpage>60</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/2542579X01666180629100020</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinheiro</surname> <given-names>J. G. O.</given-names>
</name>
<name>
<surname>Tavares</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>Y. M. B. G.</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>M. R. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Inclusion complexes of copaiba (<italic>Copaifera multijuga</italic> hayne) oleoresin and cyclodextrins: Physicochemical characterization and anti-inflammatory activity</article-title>. <source>Int. J. Mol. Sci.</source> <volume>18</volume> (<issue>11</issue>), <elocation-id>2388</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms18112388</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribeiro</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Franco</surname> <given-names>P. S.</given-names>
</name>
<name>
<surname>Lopes-Maria</surname> <given-names>J. B.</given-names>
</name>
<name>
<surname>Angeloni</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Barbosa</surname> <given-names>B. F.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>A. O.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Azithromycin treatment is able to control the infection by two genotypes of <italic>Toxoplasma gondii</italic> in human trophoblast BeWo cells</article-title>. <source>Exp. Parasitol.</source> <volume>181</volume>, <fpage>111</fpage>&#x2013;<lpage>118</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.exppara.2017.08.004</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosini</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Teixeira</surname> <given-names>S. C.</given-names>
</name>
<name>
<surname>Milian</surname> <given-names>I. C. B.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>de Souza</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Luz</surname> <given-names>L. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>LPS-mediated activation of TLR4 controls <italic>Toxoplasma gondii</italic> growth in human trophoblast cell (BeWo) and human villous explants in a dependent-manner of TRIF, MyD88, NF-&#x3ba;B and cytokines</article-title>. <source>Tissue Cell</source> <volume>78</volume>, <elocation-id>101907</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tice.2022.101907</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Ueda-Nakamura</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Dias-Filho</surname> <given-names>B. P.</given-names>
</name>
<name>
<surname>Veiga-J&#xfa;nior</surname> <given-names>V. F.</given-names>
</name>
<name>
<surname>Lima</surname> <given-names>M. M. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>
<italic>Leishmania amazonensis</italic>: Effects of oral treatment with copaiba oil in mice</article-title>. <source>Exp. Parasitol.</source> <volume>129</volume> (<issue>2</issue>), <fpage>145</fpage>&#x2013;<lpage>151</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.exppara.2011.06.016</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Ueda-Nakamura</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Dias Filho</surname> <given-names>B. P.</given-names>
</name>
<name>
<surname>Veiga-J&#xfa;nior</surname> <given-names>V. F.</given-names>
</name>
<name>
<surname>Pinto</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>C. V.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Effect of Brazilian copaiba oils on <italic>Leishmania amazonensis</italic>
</article-title>. <source>J. Ethnopharmacol.</source> <volume>120</volume> (<issue>2</issue>), <fpage>204</fpage>&#x2013;<lpage>208</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2008.08.007</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharif</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Unyah</surname> <given-names>N. Z.</given-names>
</name>
<name>
<surname>Nordin</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Basir</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Wana</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Ahmad</surname> <given-names>A. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Susceptibility of <italic>Toxoplasma gondii</italic> to ethanolic extract of <italic>Tinospora crispa</italic> in vero cells</article-title>. <source>Evid. Based Complement. Alternat. Med.</source> <volume>2019</volume>, <elocation-id>2916547</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2019/2916547</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Franco</surname> <given-names>P. S.</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Milian</surname> <given-names>I. C. B.</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Enrofloxacin and toltrazuril are able to reduce <italic>Toxoplasma gondii</italic> growth in human BeWo trophoblastic cells and villous explants from human third trimester pregnancy</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2017.0034</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sommerville</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Richardson</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>R. A. M.</given-names>
</name>
<name>
<surname>Mottram</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>C. W.</given-names>
</name>
<name>
<surname>Alexander</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Biochemical and immunological characterization of <italic>Toxoplasma gondii</italic> macrophage migration inhibitory factor</article-title>. <source>J. Biol. Chem.</source> <volume>288</volume> (<issue>18</issue>), <fpage>12733</fpage>&#x2013;<lpage>12741</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M112.419911</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Souza</surname> <given-names>G. A. G.</given-names>
</name>
<name>
<surname>da Silva</surname> <given-names>N. C.</given-names>
</name>
<name>
<surname>de Souza</surname> <given-names>J.</given-names>
</name>
<name>
<surname>de Oliveira</surname> <given-names>K. R. M.</given-names>
</name>
<name>
<surname>da Fonseca</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Baratto</surname> <given-names>L. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>
<italic>In vitro</italic> and <italic>in vivo</italic> antimalarial potential of oleoresin obtained from <italic>Copaifera reticulata</italic> ducke (Fabaceae) in the Brazilian Amazon rainforest</article-title>. <source>Phytomedicine</source> <volume>24</volume>, <fpage>111</fpage>&#x2013;<lpage>118</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phymed.2016.11.021</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Souza</surname> <given-names>A. B.</given-names>
</name>
<name>
<surname>Martins</surname> <given-names>C. H. G.</given-names>
</name>
<name>
<surname>Souza</surname> <given-names>M. G. M.</given-names>
</name>
<name>
<surname>Furtado</surname> <given-names>N. A. J. C.</given-names>
</name>
<name>
<surname>Heleno</surname> <given-names>V. C. G.</given-names>
</name>
<name>
<surname>Sousa</surname> <given-names>J. P. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Antimicrobial activity of terpenoids from <italic>Copaifera langsdorffii</italic> desf. against cariogenic bacteria</article-title>. <source>Phytother. Res.</source> <volume>25</volume>, <fpage>(2) 215</fpage>&#x2013;<lpage>220</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ptr.3244</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Souza</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Mili&#xe1;n</surname> <given-names>I. C. B.</given-names>
</name>
<name>
<surname>Rosini</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>de Ara&#xfa;jo</surname> <given-names>T. E.</given-names>
</name>
<name>
<surname>Teixeira</surname> <given-names>S. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Cyclooxygenase (COX)-2 modulates <italic>Toxoplasma gondii</italic> infection, immune response and lipid droplets formation in human trophoblast cells and villous explants</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>12709</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-92120-3</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamaru</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kikuchi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Takagi</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Wakamatsu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Horikoshi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ogiso</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Fetal therapy of severe symptomatic toxoplasmosis using azithromycin: Congenital toxoplasmosis</article-title>. <source>J. Obstet. Gynaecol. Res.</source> <volume>37</volume> (<issue>7</issue>), <fpage>953</fpage>&#x2013;<lpage>957</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1447-0756.2010.01459.x</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teixeira</surname> <given-names>S. C.</given-names>
</name>
<name>
<surname>de Souza</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Borges</surname> <given-names>B. C.</given-names>
</name>
<name>
<surname>de Ara&#xfa;jo</surname> <given-names>T. E.</given-names>
</name>
<name>
<surname>Rosini</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Aguila</surname> <given-names>F. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>
<italic>Copaifera</italic> spp. oleoresins impair <italic>Toxoplasma gondii</italic> infection in both human trophoblastic cells and human placental explants</article-title>. <source>Sci. Rep.</source> <volume>10</volume> (<issue>1</issue>), <fpage>15158</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-72230-0</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teixeira</surname> <given-names>S. C.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Lopes-Maria</surname> <given-names>J. B.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Angeloni</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Fermino</surname> <given-names>M. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Transforming growth factor (TGF)-&#x3b2;1 and interferon (IFN)-&#x3b3; differentially regulate ICAM-1 expression and adhesion of <italic>Toxoplasma gondii t</italic>o human trophoblast (BeWo) and uterine cervical (HeLa) cells</article-title>. <source>Acta Trop.</source> <volume>224</volume>, <elocation-id>106111</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.actatropica.2021.106111</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomani</surname> <given-names>J. C. D.</given-names>
</name>
<name>
<surname>Bonnet</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Nyirimigabo</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Deschamps</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Tchinda</surname> <given-names>A. T.</given-names>
</name>
<name>
<surname>Jansen</surname> <given-names>O.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>
<italic>In vitro</italic> antiplasmodial and cytotoxic activities of compounds from the roots of <italic>Eriosema montanum</italic> baker f. (Fabaceae)</article-title>. <source>Molecules</source> <volume>26</volume> (<issue>9</issue>), <fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules26092795</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veiga-J&#xfa;nior</surname> <given-names>V. F.</given-names>
</name>
<name>
<surname>Pinto</surname> <given-names>A. C.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>O G&#xea;nero <italic>Copaifera</italic> l</article-title>. <source>Quim. Nova</source> <volume>25</volume> (<issue>2</issue>), <fpage>273</fpage>&#x2013;<lpage>286</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/S0100-40422002000200016</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villena</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Aubert</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Leroux</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Dupouy</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Talmud</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chemla</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>1998</year>). <article-title>Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997</article-title>. <source>Scand. J. Infect. Dis.</source> <volume>30</volume> (<issue>3</issue>), <fpage>295</fpage>&#x2013;<lpage>300</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/00365549850160963</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lai</surname> <given-names>B. S.</given-names>
</name>
<name>
<surname>Juhas</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>Toxoplasma gondii</italic> secretory proteins and their role in invasion and pathogenesis</article-title>. <source>Microbiol. Res.</source> <volume>227</volume>, <fpage>126293</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micres.2019.06.003</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>